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ABSTRACT 
ANALYSIS OF THE INTRICACIES OF SUBSTRATE RECOGNITION OF HIGH 
MOBILITY GROUP PROTEINS AND AMINOACYL-TRNA SYNTHETASES 
USING NON-COGNATE SUBSTRATES 
by Douglas Van Iverson II 
August 2016 
The studies presented in section 1 (Chapters I-IV) focus on the design and 
development of nucleic acid four-way junctions (4WJs) to target a member of the 
high mobility group (HMG) proteins, the proinflammatory cytokine high mobility 
group box 1 protein (HMGB1). In the present study, hybrid PNA-DNA 4WJs 
based on a model DNA 4WJ were constructed to improve the thermal stability of 
4WJs while maintaining strong binding affinity toward HMGB1. An electrophoretic 
mobility shift assay (EMSA) was used to examine the binding affinity of an 
isolated DNA binding domain of HMGB1, the HMGB1 b-box (HMGB1b), toward a 
set of PNA-DNA hybrid 4WJs. EMSAs showed that HMGB1b recognizes single-
PNA hybrid 4WJs with a similar affinity to the DNA control. Circular dichroism 
(CD) spectroscopy was used to examine the structure and monitor thermal 
transitions of hybrid PNA-DNA four-way junctions in low (0.01mM Mg2+) and high 
(2.00mM Mg2+) ionic strength environments. CD analysis suggests a large 
deviation in helical structure between DNA and PNA hybrid junctions. Blunt-
ended hybrid junctions b4WJ-PNA1 and b4WJ-PNA3 had higher melting 
temperatures (Tms) than their full-length counter parts with Tms of 1.55 and 
5.43C, respectively. Junction b4WJ-PNA3 was shown capable of binding 
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HMGB1b with an affinity similar to that of its parent DNA junction and has a Tm of 
41.18C, 1.14C higher than its parent DNA junction J1 and well above normal 
body temperature, suggesting that b4WJ-PNA3 may be a viable therapeutic 
agent for targeting HMGB1 in vivo. 
 In the study presented in section 2 (Chapters V-VIII), the amino acid (AA) 
selectivity of aminoacyl-tRNA synthetases (aaRSs) was examined to investigate 
a possible role for aaRSs in genetic code development. A radiometric assay was 
used to perform an exhaustive survey of the 20 natural AAs vs. the 20 aaRSs 
from Escherichia coli (E. coli). This study presents an AA chronology of Early vs. 
Late AAs based on misactivation frequency. Findings were compared with 
current theories on the evolution of AA recruitment and codification. The results 
of this study show a correlation between misactivation frequency and the order of 
AA codification, suggesting that aaRSs may have played a role in the process of 
AA codification.  
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CHAPTER I – EXAMINING HYBRID PNA-DNA 4WJS AS POTENTIAL 
THERAPEUTIC AGENTS TO TARGET THE PROINFLAMMATORY  
CYTOKINE HMGB1  
1.1 Synopsis and Hypotheses 
Inflammation is part of the body’s response to injury or invasion and is a 
necessary part of the innate immune system. However, uncontrolled 
inflammation can cause damage to healthy tissue and exacerbate certain 
diseases and disorders. The objective of the studies presented in Chapters I 
through IV is to focus on the design and development of nucleic acid four-way 
junctions (4WJs) to target the proinflammatory cytokine, HMGB1 in an effort to 
reduce symptoms of inflammation. To date, there is no commercially available 
treatment for HMGB1-linked disorders. The rational for selecting 4WJs as ligands 
against HMGB1 is based on the multi-functional nature of the protein.  HMGB1 is 
an abundant DNA-binding protein that mediates nuclear homeostasis.1-7 It is now 
clear that HMGB1 also functions in the extracellular matrix (ECM) as a cytokine 
that initiates unintended leukocyte production.5,8-19 Due to the high cellular 
abundance of HMGB1 (106 copies per cell), it is perhaps not surprising that it is 
considered to be a biomarker and target for a variety of diseases and immune 
disorders such: atherosclerosis8,18,19, lupus10,16,18, rheumatoid arthritis16,19,20, and 
sepsis21,22. Consequently, a great deal of attention is focused toward targeting 
HMGB1 in efforts to reduce the harmful effects of inflammation associated with 
these conditions.  
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There is a need to develop novel therapeutics that target HMGB1 to treat 
chronic inflammation through pathways that attenuate damage signals without 
compromising the innate immune system. I hypothesize that immobile 4WJs 
that mimic natural intracellular ligands of HMGB1, can:  i) effectively target 
the protein and ii) block harmful immune reactions. With a view to enhancing 
the stability of 4WJs, certain DNA strands of 4WJs are replaced with the 
nonstandard nucleic acid - peptide nucleic acid (PNA). I hypothesize that 
hybrid PNA-DNA 4WJs possess enhanced thermal stability compared to 
pure DNA 4WJs. Inflammation is often associated with fever. Therefore, any 
therapeutic designed to traet inflammation will have to remain viable at elevated 
body temperatures (>37°C). The rationale for choosing PNA as a DNA analogue 
is based on studies that show duplex, triplex, and quadruplex structures 
composed of PNA-DNA have Tms up to 30% higher than pure DNA structures 
(69°C and 54°C for 15bp PNA-DNA hybrid and DNA duplexes, respectively).23-26  
Chapter I of the document focuses on the background of HMGB1, 4WJs, 
and PNA.  The subsequent chapters focus on the design, development, and 
structure of hybrid PNA-DNA 4WJs vs. the DNA 4WJ control, J1.  Next, the 
binding affinity of HMGB1b toward each hybrid 4WJ is evaluated. These data are 
followed by a more detailed investigation of the conformational stability of each 
hybrid 4WJ.  Finally, the discussion presents hypotheses that describe the 
possible connections between the structure of each hybrid 4WJ and its protein 
recognition properties. 
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An electrophoretic mobility shift assay (EMSA) was used to examine the 
binding affinity of HMGB1 toward the multi-PNA and blunt-ended hybrid 
junctions. HMGB1b recognizes single-PNA hybrid 4WJs with similar affinity to the 
DNA control, J1. All single-PNA hybrid junctions form 4:1 protein to junction 
complexes at concentrations similar to that of J1. HMGB1b recognizes multi-PNA 
hybrids but does not form stable 4:1 protein to junction complexes, as 
represented by a single band in the absence of intermediate with the multi-PNA 
substrates. CD spectroscopy was used to examine the structure and monitor 
thermal transitions of hybrid PNA-DNA four-way junctions in low (0.01mM Mg2+) 
and high (2mM Mg2+) ionic strength environments.  
1.2 High Mobility Group (HMG) Proteins 
HMG proteins are “architectural” nuclear proteins and the most abundant 
class of non-histone nuclear proteins. Architectural DNA-binding proteins, unlike 
transcription factors (TFs), do not bind in a sequence specific manner.27-29 
Architectural nuclear proteins bind preferentially to certain structural DNA motifs.  
One primary function of HMG proteins is to remodel chromatin.  During this 
process, HMG proteins bind/bend the topology of DNA within chromatin to 
facilitate the binding of TFs to specific DNA sequences.1,28,30-32 TF binding 
interactions in turn initiate gene expression.  Hence, HMG proteins are generally 
associated with gene expression vs. repression.1,3,27,33 HMG proteins also play 
an expanded role in additional nuclear processes such as genetic recombination 
and DNA repair.33,34 
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1.2.1 Classification of HMG proteins  
HMG proteins are split into three categories:  HMGA, HMGB, and HMGN.  
Each protein class is distinguished by their respective DNA recognition 
motifs.1,28,33-36 HMGA proteins contain three binding domains called AT-hook 
motifs.35,36 The AT-hook sequences of HMGA proteins possess a conserved 
PRGRP amino acid sequence. Two of the three AT-hooks are involved in DNA 
recognition and binding.35 AT-hook motifs recognize the minor groove of duplex 
DNA and induce bending.1,36 HMGN proteins affect the post-translational 
modifications (i.e. acetylation and phosphorylation) of core histones and compete 
with linker histone H1 to regulate chromatin structure.34,37 HMGN is also active in 
DNA lesion repair.33,34,38 HMGN proteins possess the conserved sequence 
RRSARLSA that serves as the DNA-binding region.38 The HMGB family of 
proteins includes seven members: HMGB1, HMGB2, HMGB3, HMGB4, HMG1, 
HMG2, and HMG2a.28 HMGB proteins’ functional DNA-binding motifs are 
referred to as “box” domains.  An HMG box domain is composed of three alpha 
helices connected by short loops to form a HTH motif.1,6,28   
1.2.2 High Mobility Group B1 (HMGB1) 
HMGB1 is the most highly abundant (106 copies/cell) of HMGB proteins.  
HMGB1 is composed of 215 amino acids that are arranged into three subunits, 
two DNA-binding “box” domains and an acidic C-terminus.29 The a- and b-box 
subunits from HMGB1 are displayed in Fig. 1 A and B, respectively.39,40 DNA 
binding occurs on the concave side of the L-shaped structure.39 This hydrophobic 
face interacts with the minor groove of DNA. Two residues within the b-box, 
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Phe106 and Lys126 (shown in green in Fig. 1B), intercalate between DNA 
strands. This induces an approximate 90° bend in the bound DNA strand.29,39 
The a-box has only a single intercalating residue, Phe38, shown in green in Fig. 
1A. The single intercalating residue of the a-box produces a less dramatic bend 
in DNA of approximately 60°.29,40  
   
Figure 1. HMGB1 a-box and b-box Structures 
(A) Solution NMR structure of HMGB1 A-box domain from human highlighting DNA intercalating residue Phe38 [PDB: 
2RTU]40. (B) Solution NMR structure HMGB1 B-box domain from rat highlighting DNA intercalating residues Phe106 and 
Lys126 [PDB: 1HME]39.  
1.2.3 Classical and Alternate Functions of HMGB1 
Like other HMG proteins, HMGB1 was initially classified as a nuclear 
protein.  In the nucleus, HMGB1 binds preferentially to bent and cruciform DNA 
(i.e. 4WJs) to control homeostatic functions such as chromatin remodeling and 
  A   B 
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genetic recombination and repair.2,41,42 With respect to chromatin remodeling, 
HMGB1 binds DNA to induce bends that alter the topology of DNA.27,43 The bent 
topology of DNA enhances TF binding at gene promoter regions. Moreover, 
HMGB1 (like HMGN proteins) can displace histones from bent DNA and relax 
structural constraints for transcription factor binding.3,43 
Extracellular HMGB1 was initially discovered as a 30-kDa heparin-binding 
protein in the developing brains of rats, and termed “amphoterin” before being 
identified as HMGB1.5,11,44 HMGB1 was shown to be required for neuronal 
outgrowth.44-46 Antibodies against HMGB1 were shown to inhibit neuronal 
outgrowth in cell cultures.44,46 HMGB1 is localized in the filopodia extending from 
the cell bodies of neurons and regulates outgrowth of axons and dendrites by 
promoting adhesion of the growing membrane edges.44 HMGB1 was further 
found to bind RAGE on the surface of rat embryonic cortical neurons, and is co-
expressed with RAGE in developing rat neuroepithelium.46    
HMGB1 has since been implicated in a variety of alternate cellular 
processes such as:  neuronal outgrowth, tumor proliferation, platelet activation, 
cell adhesion, and as a mediator of immune response.5,9,12,15,17,30,31,41,44,46-54 The 
role of HMGB1 in activation of immune response(s) has gained arguably the 
majority of attention in recent years.  With respect to the specific role of HMGB1 
in immunity, HMGB1 acts as a redox- sensitive damage-associated molecular 
pattern molecule (DAMP).17,18,49,53 HMGB1 can be released either actively by 
immune cells or passively by damaged/necrotic cells (Fig. 3A).17,48 Active 
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HMGB1 release can be triggered by stimulation of macrophages and monocytes. 
Passive release is normally associated with cellular injury.17,48,55  
As stated earlier, posttranslational modifications influence the function of 
HMGB1.5,9,18,48,52,56,57 The sequence for human HMGB1 is shown in Fig. 2. 
HMGB1 can also function in the ECM as a damage associated molecular pattern 
molecule (DAMP). In this capacity the oxidation state and posttranslational 
modifications of the protein are critical.40,48,52 The key residues that undergo 
modification are highlighted in Fig. 2 and include:  Lys2, Lys11, Lys28, Lys29, 
and Lys30 (acetylation sites highlighted maroon); Cys23, Cys45, and Cys106 
(oxidation sites highlighted in dark blue); Ser35, Ser39, Ser42, Ser46, and Ser53 
(phosphorylation sites highlighted in grey); and Lys43 (methylation site 
highlighted in light blue).5,40,48  
                    10                            20                            30                           40                            50 
MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWK  
                    60                            70                            80                            90                           100 
TMSAKEKGKFEDMAKADKARYEREMKTYIPPKGETKKKFKDPNAPKRPPS 
                             110                          120                           130                          140                           150 
AFFLFCSEYRPKIKGEHPGLSIGDVAKKLGEMWNNTAADDKQPYEKKAAK 
                              160                          170                          180                           190                           200 
LKEKYEKDIAAYRAKGKPDAAKKGVVKAEKSKKKKEEEEDEEDEEDEEEE 
                            210 
EDEEDEDEEEDDDDE 
 
Figure 2. HMGB1 sequence from human  
The A-box shown in red text, B-box in blue text, and the acidic tail in green text. Acetylation sites (maroon), oxidation sites 
(dark blue), DNA-binding (green), methylation (light blue) and phosphorylation (grey). 
Acetylation of lysine residues in the A-box eliminates electrostatic 
interaction of these residues with DNA and impedes binding.56 Acetylation of 
these lysine residues in isolated A-boxes abolishes binding to DNA 4WJs. Upon 
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acetylation, the full-length protein retains its ability to bind 4WJs through 
interactions with the B-box. In macrophages and monocytes, acetylation of lysine 
residues in the A-box precedes cytosolic translocation of HMGB1.9,56 
Phosphorylation then leads active secretion to the extracellular matrix by 
lysosomes and secretion vesicles.48,52 In neutrophiles extra cellular transport is 
induced through methylation of Lys42.18,48,52   
 
Figure 3. Relationship between HMGB1 function and posttranslational 
modifications  
A) Active and passive HMGB1 release. B) HMGB1 oxidation states. From “The Role of High Mobility Group Box 1 in 
Innate Immunity” by Lee, S.A. et. al.2014, Yonsei Med. J. 279, 20935-20940. Copyright 2014 by Yonsei University 
College of Medicine. Reprinted under Creative Commons license.48 
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The function of HMGB1 is dictated by its oxidation state (Fig. 3B).  
HMGB1 is found in the nucleus in its fully reduced form.48,52 In damaged cells, 
HMGB1 localizes within the cytosol. HMGB1 acts as a chemo-attractant in its 
fully reduced form, enhancing autophagy and promoting lysosomal degradation 
of damaged cellular components through interaction with the Beclin1-Bcl2 
complex.50,52,54 Under oxidative conditions, Cys23 and Cys45 of the A-domain 
form a disulfide bond. In the extracellular space disulfide-HMGB1 acts as a 
proinflammatory cytokine.40,48,49 In this capacity, HMGB1 forms complexes with 
or binds directly to immune receptors (Fig. 4) such as:  chemokine (C-X-C Motif) 
Ligand 12 (CXCL12), receptor for advanced glycation end products (RAGE), and 
toll-like receptor (TLR)-4 to activate the nuclear factor kappa-B (NF-κB) pathway 
and control leukocyte migration and activation.5,9,30 The complex formed between 
HMGB1 and CXCL12 increases the affinity of CXCL12 for its receptor CXCR4 
and promotes chemotaxis.5,18 Binding of HMGB1 to RAGE and TLR4 activates 
the NF-κB pathway.12,16,51,58    
Fully oxidized HMGB1 loses its immune function.5,48 The oxidation of 
Cys106 has been shown to promote relocalization from the nucleus to the 
cytoplasm in apoptotic cells and promotes immune tolerance.9,40,48,59 This 
process is promoted by cellular reactive oxygen species (ROS). Caspase 
activation targets the mitochondria to produce ROS during apoptosis. Cys106 is 
oxidized by these mitochondrial ROS eliminating the proinflammatory activity of 
HMGB1. This process has been shown to be necessary for neutralizing HMGB1 
as a danger signal and promoting immune tolerance of apoptotic cells.60 
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Figure 4. HMGB1 extra nuclear interactions 
HMGB1 binding to immune receptors RAGE and TLR4, and activation of CXCR4 through interaction with CXCL12 . From 
“HMGB1 and leukocyte migration during trauma and sterile inflammation” by Venereau et al. 2013, Molecular Immunology 
55, 76-82. Copyright 2013 by Elsevier. Reprinted with permission of the author.61 
1.2.4 HMGB1 and Disease Pathogenesis 
HMGB1 is gathering a great deal of attention as a disease biomarker and 
therapeutic target. A growing number of studies link unintended HMGB1 
signaling with pathogenesis in a number of diseases and immune disorders   
(Fig. 5) such as:  atherosclerosis8,18, diabetes62,63, lupus10,18, rheumatoid 
arthritis16,18,20, and sepsis21,22,53. HMGB1 contributes to atherosclerosis by 
promoting vascular inflammation and lesions.8  HMGB1 is found at elevated 
levels in the blood plasma of patients with type 2 diabetes and is up regulated in 
response to high glucose levels.62-64 HMGB1 promotes the production of 
proinflammatory cytokines through activation of the NF-κB signaling pathway 
exacerbating conditions such as diabetic neuropathy (DN).62  
HMGB1 expression was shown to correlate with the severity of symptoms 
of systemic lupus erythematosus (SLE) in mice.10 HMGB1 was shown to 
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exacerbate renal pathology by enhancing macrophage inflammatory response 
through activation of RAGE.10 Active HMGB1 release has been observed at sites 
of joint inflammation in mice with arthritis. Injection of HMGB1 into the joints of 
healthy mice induced arthritis in these locations.16,20  
During the late phase of sepsis, HMGB1 release activates the coagulation 
system and results in disseminated intravascular coagulation.22 HMGB1 secreted 
from dying cells induces the release of additional HMGB1 and other cytokines 
from macrophages and other cell types.22,50 HMGB1 has also been shown to 
mediate acute lung injury and acute kidney injury during sepsis through activation 
of the NF-κB pathway.21,22 
 
Figure 5. HMGB1 and disease 
From “Schmetterlingserythem bei systemischem Lupus” by Doktorinternet 2013, Wikimedia Commons. Copyright 2013 by 
Doktorinternet. Reprinted under Creative Commons liscence. From “Myocardial Infarction or Heart Attack,” by Blausen 
Medical Communications, Inc. 1997, Wikimedia Commons. Copyright 1997 by Blausen Medical Communications, Inc. 
Reprinted under Creative Commons license. From “Chilblains, also called perniosis,” by Sapp 2007, Wikimedia 
Commons. Copyright 2008 by Sapp. Reprinted under Creative Commons liscence. From “Front side of the left knee,” by 
Stefan de Konink 2011. Wikimedia Commons. Copyright 2011 by Stefan de Konink. Reprinted under Creative Commons 
liscence. 
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1.2.5 Strategy to Target HMGB1 
HMGB1 provides a target for novel therapeutics to treat chronic 
inflammation through pathways that attenuate damage signals without 
compromising the innate immune system. In mouse models with diabetes 
HMGB1 inhibition reduced the up regulation of pro-inflammatory cytokines in 
response to high glucose.62,63 In mouse models, antibodies against HMGB1 have 
been shown to alleviate inflammation associated with rheumatoid arthritis and 
prevent the progression of arthritis.20 
Cell and animal model studies have found many pharmacologically active 
compounds with the ability to suppress immune response by blocking HMGB1, 
though many of these compounds were expensive, showed cytotoxicity at 
required dosages, or have harsh side effects.12,20,49  Our strategy is to develop 
cruciform nucleic acid structures (i.e. 4WJs) composed of DNA and PNA as 
ligands against HMGB1. These hybrid PNA-DNA 4WJs mimic the natural DNA 
4WJ ligands of HMGB1 in its role in genetic recombination. Several in vitro 
studies show that HMG proteins bind 4WJs with binding constants at nM 
range.66,67 Small (32bp – 28bp) 4WJs were developed to avoid immunogenicity 
associated with larger DNA sequences.15,65 4WJs are also able to bind HMGB1 
in 4:1 protein to junction complexes offering a distinct advantage over the single 
binding sites of duplex structures. The hybrid 4WJs are based on the model 
immobile DNA 4WJ, J1. J1 is composed of four asymmetric DNA strands that 
ensure the lattice of the molecule is immobilized or “locked”.  The long-term 
objective is to reassign 4WJs to the ECM to target HMGB1. 4WJs are intended to 
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sequester HMGB1 and block unintended binding interactions between HMGB1 
and immune receptors that initiate immune dysfunction. With respect to unnatural 
substrates, PNA are used to replace DNA sequences within the lattice of J1 to 
enhance the stability of the resulting hybrid DNA-PNA 4WJs. 
We suspect that the binding affinity of HMGB1 toward 4WJs (Kd ≈ 10 – 
160 nM) is strong enough to  prevent HMGB1 binding to immune receptors.66,67 
HMGB1 binds receptors such as RAGE and toll-like receptor 4 (TLR-4) with 
binding constants that range from Kd ≈ 10.0 - 100.0 nM).46 Inhibition of HMGB1 
by hybrid 4WJs is hypothesized to alleviate inflammation by scavenging HMGB1 
from the ECM.  This approach is designed to remove/prevent the interaction of 
HMGB1 with RAGE and TLRs to effectively shut off immune responses. 
1.3 DNA Four-Way Junctions 
DNA 4WJs, also known as Holliday junctions, are key intermediate for 
genetic recombination and double strand break repair.68,69 These processes are 
essential to promoting genetic diversity and maintaining genomic stability. One of 
the most extensive networks of Holliday junctions is found in the homologous 
recombination (HR) steps of meiosis illustrated in Fig. 6. In the initial stage of 
meiotic HR, double strand breaks (DSBs) are produced at numerous 
chromosomal DNA sites to produce single strand 3’ overhangs. Next, DNA 
recombinases bind the 3’ overhangs and search for an intact homologous dsDNA 
sequence. The recombinases then promote strand invasion by the ssDNA ends 
to form displacement loops. The initial strand invasion intermediates can be 
processed by one of two pathways: rejoining of the broken strands by synthesis 
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dependent strand annealing (SDSA) or by double strand break repair 
(DSBR).69,70 The SDSA pathway results in displacement of the invading strand 
and leads to non-crossover products. The DSBR pathway is the result of a more 
stable strand invasion intermediate and leads to a second end capture. This 
produces a double 4WJ that is eventually resolved to allow chromosome 
segregation.68-72 
 
Figure 6. Holliday junctions in genetic recombination. 
Branch migration is required in genetic recombination in order to produce 
crossover products. However, branch migration makes it difficult to probe the 
structural dynamics of 4WJs. Hence, a great deal of effort was put forth to 
assemble locked or “immobilized” 4WJs that form stable conformational 
isomers.73,74 An algorithm developed by Seeman and Kallenbach, designed to 
minimize sequence symmetry to ensure that the junction lattice is immobilized, 
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was used to devise a series of immobile 4WJs.73 The sequence identity of each 
strand of J1 minimizes symmetry (to ensure that the junction lattice is 
immobilized), while maintaining thermodynamic stability of the junction. The 
algorithm is based on a set of rules that prevents:  i) the repeat of four 
consecutive nucleotides in any two strands and ii) the presence of complimentary 
sequences in an arm and branch point.73,75,76 The sequence of the immobilized 
junction J1 is displayed in Fig. 7.  
 
Figure 7. Model immobile 4WJ J1  
Individual strands are labeled as 101, 102, 103, AND 104, respectively. 
Subsequent studies using a variety of biophysical techniques such as:  gel 
electrophoresis, chemical foot printing, enzymatic foot printing (protection 
assays), fluorescence resonance energy transfer (FRET), nuclear magnetic 
resonance (NMR), and X-ray studies reveal that the global conformation of 4WJs 
fluctuate between extended or “open” structures and compact “stacked” 
structures.77-81 The extended conformer, referred to as open-X, has four-fold 
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symmetry (90 rotational symmetry) with all four arms pointing away from the 
center (Fig. 8A). The compact or stacked-X isomers shown in Fig. 8B and C 
possess two-fold symmetry (180 rotational symmetry) and can populate two 
conformational isomers.  Each stacked-X isomer contains two continuous strands 
and two crossover strands. The continuous strands of the stacked-X isomers 
have single axes throughout their respective helices. The crossover strands 
switch helices at the branch or strand exchange point. Studies of J1 have shown 
a preference for one of the isomers based on the sequences flanking the branch 
point.75,76,82 
 
Figure 8. Open-X vs. stacked-X conformational isomers  
(A) The open conformer showing fully extended arms. (B) and (C) display the I/II and III/IV stacked-X conformers, 
respectively. 
The structure of 4WJs is highly dependent upon the concentration of 
cations such as Na+ and Mg2+.81,83-85 Fig. 9 shows X-ray crystal structures of two 
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synthetic immobile 4WJs in the open-X (Fig. 9A)86, and in the stacked-X 
conformation (Fig. 9B).87 In the absence of cations, electrostatic repulsion 
between phosphates causes the helical arms to extend into the open-X 
conformation (Fig. 9A). When the concentration of Mg2+ 100 μM, the charge 
repulsion between negatively charged phosphate backbones is greatly reduced 
promoting the transition from an open conformer to a stacked-X conformer.80,82,88 
                 
Figure 9. X-ray crystal structures of synthetic 4WJs  
(A) X-ray crystal structure of a DNA 4WJ in an open conformation at a resolution of 2.8 Å [PDB: 1XNS]86. (B) X-ray crystal 
structure of a DNA 4WJ in a stacked-X conformation at a resolution of 1.94 Å [PDB: 4GQD]87. 
The current studies focus on the immobilized 4WJ, J1.  Electrophoresis 
experiments confirmed that a 1:1:1:1 ratio of each strand of J1 forms a stable 
complex.73,74 CD and NMR analyses revealed that 4WJs (including J1) posses B-
DNA helical structure.74,82,88,89 With respect to local heterogeneity within the 
junction lattice, J1 (Fig 10A) was shown to prefer a stacking arrangement of arms 
I/II - III/IV with strands 101 and 103 as the continuous strands and 102 and 104 
as the crossover strands analogous to Fig. 9B.66,74,76,90 Examination of a J1 
derivative, J2, with the CG and AT pairs at the branch point of arms III and IV 
swapped revealed a much weaker preference for the I/II - III/IV isomer.89,90 Under 
          A    B 
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conditions where J1 exists solely in the I/II - III/IV stacked-X isomeric form, J2 
exists as a 5:1 mixture of the I/II - III/IV and I/IV - II/III isomers shown in  Fig. 
10B.89,90 Fig. 10C shows another J1 derivative, JEPS, with AT pairs replacing the 
GC pairs at the ends of the junction arms. Studies utilizing FRET analysis 
revealed that JEPS presented the same preference for the I/II - III/IV stacking 
conformation as J1.78 It can be concluded from these studies that the bases at 
the ends of the junction arms have little effect on the stacking arrangement while 
the sequence near the branch point is a strong factor in determining the 
preference for and stability of a particular structural isomer.78,89,90 
 
Figure 10. 4WJ Isomerization 
Each junction is shown in the open-X conformation at the top. The preferred stacked-X isomer is shown at the bottom. (A) 
J1 shown to the left with a single preferred isomer. (B) J2 shown in the middle has no clear preference for a specific 
stacked-X isomer. (C) JEPS shown to the right with its preferred stacked-X isomer. 
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 Therapeutics based on nucleic acids have shown moderate success in 
targeting HMGB1. One study utilized DNA beads coated with DNA oligomers to 
sequester HMGB1 in the intestines of mice after induction acute colitis. Oral 
administration of the beads was shown to sequester HMGB1 from the gut and 
reduce levels in serum samples.15 This study determined that larger DNA 
constructs (i.e. 4WJs) show greater affinity for HMGB1 in vitro.15 However, the 
4WJ constructs did not bind appreciably at low pH. I hypothesize that modifying 
the 4WJ lattice by inserting more chemically stable nucleic acid analogs (i.e. 
PNA) will produce enhanced in vivo stability. PNAs offer several properties that 
make them ideal candidates for use as DNA analogs in 4WJs. PNAs form stable 
hybrid structures with DNA through Watson-Crick base pairing. The global 
conformations of PNA-DNA duplexes and 4WJs largely match the global 
conformations of corresponding DNA structures. However, PNA-DNA structures 
do show changes in local helical conformation compared to DNA structures.91-95 
The uncharged PNA backbone provides decreased charge repulsion between 
strands, increasing the thermal stability of nucleic acid structures containing PNA 
strands. This is evidenced by an increase in Tms of PNA-DNA hybrid duplexes 
over their pure DNA counterparts by up to 30%.24,25,96 The peptide backbone of 
PNA also provides nuclease resistance to hybrid structures.57,97    
1.4 Nonstandard Nucleic Acid - Peptide Nucleic Acid (PNA) 
PNAs are nucleic acid analogs that are composed of polyamide linkages 
vs. sugar/phosphate bonds.  PNAs were originally studied as gene-targeting 
drugs that were designed to form complementary base pairs within gene 
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regulating regions of DNA.98,99 PNAs contain standard nucleobases, however, 
the sugar-phosphate backbone is replaced with an amide backbone composed of 
aminoethyl glycine (AEG) units. AEG was selected as the original PNA backbone 
based on computer models that show an AEG linkage provides a similar distance 
between nucleobases as a sugar phosphate backbone.98,99 Fig. 11 shows a 
comparison of the functional units of PNA vs. DNA. PNAs contain the same 
nucleobases as DNA or RNA. Therefore, PNAs form standard Watson-Crick 
base pairs with PNA, DNA or RNA templates.100 
 
Figure 11. DNA sugar phosphate backbone vs. PNA AEG backbone  
(A) A sugar phosphate backbone unit of DNA. (B) An AEG backbone unit of PNA. 
The polyamide backbone of PNA possesses several inherent structural 
and biochemical advantages vs. DNA and RNA.  The polyamide backbone of 
PNA is not recognized by cellular nucleases making PNA more resistant to 
digestion than DNA and RNA.57,97 The uncharged PNA backbone provides 
decreased charge repulsion between strands, increasing the stability of nucleic 
acid structures containing PNA strands.24,25,96 Studies examining 24 - 30bp DNA 
and PNA-DNA duplexes showed higher Tm values for the PNA-DNA hybrids. 
 
A	 B	
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DNA duplexes showed Tms between 47.8 and 53.5C with the corresponding 
PNA-DNA hybrids displaying Tms between 61.8 to 68.5C.24,26 Corresponding 
PNA-RNA duplexes showed even higher Tms up to 72.3C.24 Hence, hybrid PNA-
DNA and PNA-RNA duplexes possess enhanced thermal stability vs. pure DNA 
and RNA duplexes.24,25,85,96,100,101 These features have provided the impetus to 
develop PNA-derived therapeutics or biotechnology reagents for many years. 
 
Figure 12. Schematic of DNA/PNA duplex 
 Duplex obeys Watson-Crick hydrogen bonding rules in an antiparallel orientation. 
As stated earlier, PNAs bind nucleic acids via Watson-Crick base pairing. 
Thermal stability studies of hybrid duplexes showed them to be more stable in an 
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anti-parallel orientation with the 3’ end of the DNA aligned with the N-terminus of 
the PNA.24,100-102 Fig. 12 shows a schematic of a PNA-DNA duplex oriented in an 
anti-parallel direction with a standard Watson-Crick hydrogen-bonding pattern.  
Previous x-ray and NMR studies show that PNA duplexes can adopt 
several discrete structures.91,92,94,103,104 These conformers come as a result of 
rotation around the backbone amides, and transitions between them are slow, 
reflecting the energy barrier between conformations resulting from the 
coordinated motion required to avoid steric clashes.92,103 PNA-DNA duplexes, 
however, showed only a single conformation.91,93,105 These hybrid duplexes show 
structural alterations in both strands. PNA-DNA duplexes also show a slight 
perturbation of base-stacking arrangement compared to the DNA/DNA 
duplex.93,105 Fig. 13 shows x-ray crystal structures of DNA/DNA (A)106, PNA-DNA 
(B)105, and PNA/PNA91 (C) duplexes. The structural similarities between 
DNA/DNA and PNA-DNA duplex helicies are evident from Fig. 13. However, 
PNA-DNA duplexes show a slight increase in the rise per bp (3.5 Å) compared to 
B-form DNA duplexes (3.3Å).94 The results of previous structural studies suggest 
that PNA-DNA hybrid structures adopt helical conformations that are quite similar 
to DNA structures. These structural similarities no doubt facilitate the binding of 
PNA-DNA hybrids to DNA binding proteins like HMGB1.   
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Figure 13. NMR/X-ray Structures of Nucleic Acid Duplexes 
(A) X-ray crystal structure of a DNA/DNA duplex at a resolution of 1.99 Å [PDB: 4HLI]106. (B) NMR solution structure of a 
PNA-DNA hybrid duplex [PDB: 1PDT]105. (C) X-ray crystal structure of a PNA/PNA91 duplex at a resolution of 1.7 Å [PDB: 
1PUP]. DNA strands are shown in orange as cartoons. PNA strands are shown in green as stick structures.  
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CHAPTER II - MATERIALS AND METHODS 
2.1 Polyacrylamide Gel Electrophoresis (PAGE) 
Nondenaturing PAGE has been used extensively to characterize DNA 
4WJs. Junction formation is observed as a reduction in electrophoretic mobility of 
the junction vs. single and double-stranded DNA.35,80,81,84,107-109 This technique 
has also been used to observe changes in junction conformation in the presence 
of metal ions such as Na+ and Mg2+.81,107,108 PAGE assays have also been used 
to determine whether junctions show a preference for a particular stacked 
isomer.80,107-109 In these studies, the junction arms were truncated by enzymatic 
cleavage to generate multiple products that resemble either stacked-X or open-X 
conformers. The resulting migration pattern(s) of the cleaved junctions are used 
as controls to identify the mobility of stacked-X vs. open-X isomers of 
uncharacterized junctions.81,108,109 These studies indicate that stacked-X 
junctions migrate faster than open-X. The junctions investigated here all 
presumably form stacked-X conformers based on the high level of Mg2+ (1 mM) 
in the analysis buffer. 
2.1.1 Four-Way Junction Formation 
The sequences for J1 are: 101*, 5’-CGCAATCCTGAGCACG-3’; 102, 5’-
CGTGCTCACCGAATCG-3’; 103, 5’-GCATTCGGACTATGGC-3’ and 104, 5’-
GCCATAGTGGATTGCG-3’. The sequences for 4WJ-PNA1 are: PNA1, H-
CAATCCTGAGCA-K-NH2; 102, 5’-CGTGCTCACCGAATCG-3’; 103*, 5’-
GCATTCGGACTATGGC-3’ and 104, 5’-GCCATAGTGGATTGCG-3’. The 
sequences for b4WJ-PNA1 are: PNA1, HCAATCCTGAGCA-K-NH2; b102, 5’-
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TGCTCACCGAATCG-3’; 103*, 5’-GCATTCGGACTATGGC-3’ and b104, 5’-
GCCATAGTGGATTG-3’. The sequences for 4WJ-PNA3 are: 101*, 5’-
CGCAATCCTGAGCACG-3’; 102, 5’-CGTGCTCACCGAATCG-3’; PNA3: H-
ATTCGGACTATG-K-NH2 and 104, 5’-GCCATAGTGGATTGCG-3’. The 
sequences for b4WJ-PNA3 are: 101*, 5’-CGCAATCCTGAGCACG-3’; nb102, 5’-
CGTGCTCACCGAAT-3’; PNA3: H-ATTCGGACTATG-K-NH2 and 104, 5’-
GCCATAGTGGATTGCG-3’. The sequences for 4WJ-PNA1,3 are: PNA1, 
HCAATCCTGAGCA-K-NH2; 102, 5’-CGTGCTCACCGAATCG-3’; PNA3: H-
ATTCGGACTATG-K-NH2 and 104*, 5’-GCCATAGTGGATTGCG-3’. The 
sequences for b4WJ-PNA1,3 are: PNA1, H-CAATCCTGAGCA-K-NH2; db102, 5’-
TGCTCACCGAAT-3’; PNA3: H-ATTCGGACTATG-K-NH2 and bf104*, 5’-
CATAGTGGATTG-3’. Strands labeled with fluorescein are denoted with an 
asterisk (101*, 103*, nb104* and bf104*). Each fluorescent strand was purified 
via HPLC; each non-labeled DNA strand was purified via denaturing 
polyacrylamide gels. All DNA was purchased from Integrated DNA Technologies 
(IDT). Junctions were formed by mixing 25M of a fluorescein labeled strand with 
125M of each unlabeled strand. This mixture was lyophilized and resuspended 
in an annealing buffer consisting of 50 mM Tris-HCl (pH 7.5) and 1.0 mM MgCl2. 
The reconstituted strands are then incubated at 95°C for 2 min, followed by 
cooling to room temperature for 12-16 h. The 4WJs were loaded onto 15% mini-
PROTEAN native polyacrylamide gels (BioRad) and run for 1-5 h at 4°C. The gel 
running buffer was composed of 0.5 X TBE (MgCl2 buffer (45 mM Trisma, 45 mM 
boric acid, 1.0 mM EDTA and 1 mM MgCl2), pH 7.6. The gels were subsequently 
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scanned with a Typhoon 9400 Phosphorimager in fluorescence mode at 530 nm 
using an excitation wavelength of 488 nm and a light pollution filter blocking 
wavelengths below 510 nm.  Gels were scanned at PMT settings that ranged 
between 400 and 800. 
2.1.2 Electrophoretic Mobility Shift Assays (EMSAs) 
EMSAs are used to examine the protein recognition properties of the 
hybrid 4WJs toward the recombinant DNA binding protein, HMGB1b. The binding 
affinity of the previously uncharacterized junctions: b4WJ-PNA1, b4WJ-PNA3, 
4WJ-PNA1,3 and b4WJ-PNA1,3 are evaluated with HMGB1b. A constant 4WJ 
concentration of 500nM was used with HMGB1b:4WJ molar ratios ranging from 
3.2:1 (1.6 are evaluated with HMGB1b. A constant 4WJ concentration of 
500nM was used with HMGB1b:4WJ molar ratios ranging from 3.2:1 (1.6 1b. 
composed of 0.5 X TBE (MgClDNA s2 and 10% (w/v) glycerol. Each sample is 
loaded onto 15% Mini-PROTEAN TBE precast native polyacrylamide gels 
(BioRad). Gels are run at 4°C in a 0.5 X TBE buffer composed of 45 mM Trisma, 
45mM boric acid, 1.0mM EDTA and 1mM MgCl2 (pH 7.6) for 6-8 h. The gels 
were subsequently scanned with a Typhoon 9400 Phosphorimager. Each EMSA 
represents at least three independent runs/junction. 
2.2 Circular Dichroism (CD) Analysis of Nucleic Acids 
2.2.1 CD Analysis of Classic Nucleic Acids  
The CD signal of nucleic acids arises from the stacking geometries of the 
bases.110-112 Differences in CD spectra of A- and B-DNA arise from the 
respective conformations of the backbone sugar moiety.110,112 Fig. 14 shows a 
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diagram of the two isomers. The deoxyribose and ribose sugars of A-DNA and 
RNA have an endo pucker at the C3’ position while the deoxyribose sugar of B-
DNA has an endo pucker at the C2’ position.110 
  
Figure 14. Differences in the endo pucker of DNA deoxyribose sugar A- and B-
DNA structures. 
From “Circular dichroism techniques:biomolecular and nanostructural analyses- a review,” by Ranjbar et al. 2009, Chem. 
Biol. Drug Des. 74, 101-120. Copyright 2009 by John Wiley and Sons. Reprinted with permission of the author.110 
A consequence of this isomerization is a shift in the helical structure. Fig. 
15 displays 3D-models of A- and B-DNA. A-DNA, shown in Fig. 15A, has a much 
narrower major groove and wider minor groove compared to B-DNA. Fig. 15B 
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shows the more common B-DNA structure with a wide major groove and narrow 
minor groove. These changes give rise to the differing CD spectra of A- and B-
DNA shown at the bottom of Fig. 14. The spectrum for B-form DNA is shown at 
the bottom right of Fig. 14. The B-DNA spectrum contains characteristic positive 
and negative bands near 280nm and 240nm, respectively. These peaks are 
usually comparable in shape and magnitude. Smaller positive and negative 
absorption bands near 220nm and 205nm, respectively, are also commonly 
observed. The spectrum of A-form DNA is shown at the bottom left of Fig. 14 
shows a strong negative peak at 205nm and a strong positive near at 
270nm.110,112,113 
 
Figure 15. Example DNA duplex structures 
(A) B-DNA shown in red. (B) A-DNA shown in blue. 
The CD spectra of duplex DNA most commonly display a B-DNA pattern. 
However, deviations from the classical B-DNA conformation have been 
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observed, especially under dehydrating conditions.112,114,115 Analyses of DNA 
three way junctions (3WJs) have shown the global conformation of the junction 
can affect the helical structure of the junction arms. Changes in the stacking 
arrangement of 3WJs have been shown to promote transition from a B- DNA 
conformation to a more A- DNA helical conformation. CD spectra of these 
junctions produced a strong negative peak near 210nm, indicative of A-
DNA.114,115  
CD spectroscopy can also be used to characterize DNA 4WJs. Like DNA 
duplexes, DNA 4WJs typically show a strong preference for B-like helical 
conformations.74,75,89,96,103 CD spectroscopy has also been used to show that the 
sequences flanking the junction branch point have a large impact on the global 
conformation of 4WJs.75,78,90 Junctions with branch points capable of migrating 
along the arms are termed “mobile”, while those with branch points locked into 
place are termed “immobile”. Immobile junctions contain asymmetric sequences 
only capable of pairing in a single configuration. CD studies were essential to 
confirm PAGE analysis of mobile vs. immobile DNA 4WJs. Mobile and immobile 
4WJ differ by the positions of the bases at the junction branch point.  Immobile 
4WJs tend to possess more GC bases at the junction branch point to help 
immobilize or lock the junction lattice.73-76,89 The CD studies show that the 
repositioning of GC and AT bp at the junction branch point of 4WJs produced a 
blue shift and decrease in intensity in the peak near 280nm indicating a shift in 
structure.75 These sequence changes presumably contribute to the loss of 
stability of the preferred isomerization state.75,78,90 
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2.2.2 CD Analysis of PNA 
The polyamide backbone of PNA is achiral and does not produce a CD 
signal. However, incorporating chiral molecules into the backbone can induce 
handedness of single PNA strands and duplexes.95,99,103,104,116,117 The chiral 
moiety can be placed at either PNA terminus 95,103,104,116 or internally 103,117. 
Examination of a variety of AAs showed Lys to be an efficient promoter of PNA 
helix handedness95,103,116, while also improving PNA solubility99. To date, all 
studies indicate that, when attached to a PNA, L-AAs produce left-handed 
helices and D-AAs generate right-handed helices.95,103,104,116,117 The direction and 
magnitude of PNA handedness are based on a combination of factors such as:  i) 
the identity of the AA side chain, ii) the stereochemistry of the AA, iii) the position 
of the AA within the PNA backbone and iv) the sequence of the final nucleotides 
attached to the AA.95,103,104,116,117 Attaching the chiral ligand to the C-terminus 
was also shown to more efficiently induce handedness in PNA helices.95 Lys 
attached to a C (C-Lys) was shown to produce a much more intense CD signal 
than A-Lys or T-Lys. G-Lys produced a weak signal corresponding to a structure 
of opposite helicity from C-, A-, and T-Lys.95 
With respect to the analysis of PNA-DNA hybrid structures, the strength of 
signal is based predominantly on the presence of chiral DNA strand.  PNA-DNA 
duplexes always form right-handed helices regardless of the conformation of the 
unbound PNA strand.100,103,117 CD analysis showed PNAs exhibiting right-handed 
character to bind DNA in an anti parallel fashion, while those exhibiting left-
handed character bind in a parallel fashion.103,117 
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2.2.3 CD Thermal Denaturation Analysis 
Ultraviolet (UV) and CD spectroscopy have been used extensively to 
examine thermal denaturation and structural transitions of nucleic acid 
structures.26,66,75,84,85,92,96,101,104,112,114,115,118-122 These studies yield data on the 
relative stabilities of nucleic acid structures, usually given as a melting 
temperature (Tm). These studies allow the determination of cooperativity in 
melting and the presence of two-state or gradual transition.24,26,112,113,123 
By normalizing the upper and lower baselines of the melting curves to 1 
and 0, respectively, the Y-axis can be redefined to reflect the fraction of 
DNA/PNA strands in junction form (α). The value of α directly reflects the fraction 
strands in junction form. Therefore, at the Tm, α is equal to 0.5. Differentiating the 
melting curves yield plots of δα /δT vs. T, where δα /δT is the change in fraction 
of DNA/PNA strands in junction form over change in temperature and T is 
temperature. Calculation of van’t Hoff enthalpies (ΔHVH) was done using the 
equation below: 
                Eq. 1 
Eq. 1 was derived from a more general form of van’t Hoff’s equation to 
extract thermodynamic data for tetramolecular processes such as 4WJ formation 
and yields van’t Hoff transition enthalpies (ΔHVH) at the Tm.24,26,121,123 
Alternatively, ΔHVH was calculated using the full width (Eq. 2) and half width (Eq. 
3) of the differentiated melting curve at the half-height.24,123 The following two 
general forms of van’t Hoff’s equation are used for these calculations: 
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                                 Eq. 2 
                              Eq. 3 
Both B and B’ are association reaction constants for polynucleic acids that 
depend on the molecularity (n) (i.e. the number of strands) of the process and 
are in units of cal/mol-K. B is used for the calculation of ΔHVH using the full width 
(T1 to T2) of the melt curve first derivatives. B’ is used for the calculation of ΔHVH 
using the half width (Tmax to T2) of the melt curve first derivatives. Values for B 
and B’ are 15.40 and 5.63 cal/mol-K, respectively, reported in previous work by 
Marky and Breslauer.123 
Rescaling the melting curve still yields an X value at the minima (Tmin) 
corresponds to the Tm. The Y value at the minima or Tm is δα /δTm. These values 
for Tm and δα /δTm can be plugged into Eq. 1 to yield ΔHVH. Alternatively, values 
for T1 and T2 taken at (δα /δT)0.5 can be plugged into Eq. 2 to yield ΔHVH. A third 
method used to calculate ΔHVH (Eq. 3) relies on Tm and T2 taken at (δα 
/δT)0.5.24,123 
2.2.4 CD Spectroscopy of 4WJs 
CD spectra were recorded using Jasco J-815 spectrometer. A 2.0 μM 
solution of each 4WJ was prepared in CD analysis buffer: 20 mM HEPES, 30mM 
NH4Cl, 200 mM KCl, 2 mM DTT, and 10% glycerol. The low Mg2+ CD buffer 
contained 100 μM MgCl2; the high Mg2+ CD buffer contained 2 mM MgCl2. All 
spectra were measured in a 0.1 cm path-length quartz cuvette; spectra were 
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recorded from 320 to 200 nm in 1.0 nm increments at 4°C. The thermal 
denaturation profile of each 4WJ was monitored under the same buffer 
conditions (low and high Mg2+) at a fixed wavelength (maxima near 275 nm) from 
4 to 100°C. The Tm values were calculated by the fitting the average value of at 
least three independent scans to a sigmoidal curve equation using GraphPad©..  
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CHAPTER III - RESULTS 
3.1 PAGE Analysis of Native and Hybrid PNA-DNA 4WJs  
The six hybrid PNA-DNA 4WJs being investigated for HMGB1b binding 
capacity are shown in Fig. 16, along with the DNA control J1. EMSAs were used 
to examine the protein recognition properties of the hybrid 4WJs toward the 
recombinant DNA binding protein, HMGB1b. Each hybrid 4WJ contains PNA 
strand(s) at the 101 and/or 103 positions (Fig. 10). Strands 101 and 103, 
representing the continuous strands of the J1 stacked-X conformer, were 
selected as the initial replacement strands.  Future studies will focus on replacing 
strands 102 and 104.  
PNA length was limited to 12 residues in order to mitigate problems 
associated with synthesis of longer PNA sequences. As a result, certain hybrids 
(4WJ-PNA1, 4WJ-PNA3, and 4WJ-PNA1,3) have DNA strands that are 4 
nucleotides longer than the corresponding PNA strands.  Our initial report 
showed that the presence of DNA overhangs did not prohibit the formation of 
4WJ-PNA1, 4WJ-PNA3.66 However, the free motion of these DNA overhangs may 
result in structural instability of the hybrid junctions. Here the effects of truncating 
these DNA overhangs were investigated. Hybrid junctions b4WJ-PNA1, b4WJ-
PNA3, and b4WJ-PNA1,3, shown at the bottom of Fig. 16, contain truncated DNA 
sequences in positions complementary to PNA strands. DNA sequences were 
truncated to match the length of PNA sequences, producing blunt-ended junction 
arms. 
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Figure 16. Diagram of Hybrid 4WJs  
From top left: J1, 4WJ-PNA1, 4WJ-PNA3, 4WJ-PNA1,3, b4WJ-PNA1, b4WJ-PNA3, and b4WJ-PNA1,3     
Gel electrophoresis was used to confirm junction formation.  Stable 4WJ 
formation is evidenced by a significant reduction in electrophoretic mobility of the 
junction compared to single strands of DNA. Fig. 17 illustrates the differences in 
mobility between the 101 strand (lane 1) and junctions (lanes 2-9).  J1 is loaded 
in lanes 2 and 9 to give a more accurate comparison of electrophoretic mobility of 
each hybrid vs. the control.  Despite the reduction in charge from their peptide 
backbones, each single PNA hybrid 4WJ (Fig. 17 lanes 3-6) showed migration 
patterns similar to J1. The multi PNAs (Fig. 17 lanes 7 and 8), with a substantial 
reduction in charge, showed only a slight reduction in mobility. PAGE analysis 
showed the multi PNA hybrids migrate approximately 90 - 95% the distance of J1 
and the single-PNA constructs. These results match those of previous studies 
that showed electrophoretic mobility of hybrid junctions to be a function of size 
and conformation, with little effect from the reduction in charge due to the PNA 
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backbone.81,107,124 Studies have shown that the difference in electrophoretic 
mobility of PNA-DNA triplexes was strongly dependent on the shape of the 
triplex.124 More specifically, triplexes that possessed a significant bend migrated 
more slowly than linear triplexes. The 4WJs examined here migrate together due 
to similarities in size (24-32bp) and global conformation (stacked-X). High 
mobility bands present in the PNA1 constructs (Fig. 17 lanes 3 and 4) were an 
area of concern as they may be the result of contaminating structures (i.e. 
duplexes or triplexes) that promote the assembly of larger structures (i.e. non-
4WJ tetramolecular DNA assemblies containing multiple copies of one or two 
strands) that mimic the electrophoretic mobilities of 4WJs. A series of controls 
were devised (Fig. 18-20) to test each junction for the presence of higher order 
contaminating structures composed of two and three strand combinations. 
 
Figure 17. Nondenaturing Polyacrylamide Gel of Hybrid 4WJs. 
 Lane 1) 101, 2) J1, 3) 4WJ-PNA1, 4) b4WJ-PNA1, 5) 4WJ-PNA3, 6) b4WJ-PNA3, 7) 4WJ-PNA1,3, 8) b4WJ:PNA1,3 and 9) 
J1. 
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The data in Fig. 18 - 20 display the electrophoretic mobility patterns of six 
hybrid PNA–DNA 4WJs vs. i) J1 and ii) different combinations of potentially 
contaminating strands of DNA. Fig. 18 shows 4WJ-PNA1 and b4WJ-PNA1. Fig. 
19 shows 4WJ-PNA3 and b4WJ-PNA3. Fig. 20 shows 4WJ-PNA1,3 and b4WJ-
PNA1,3. The contaminating strands are composed of single strands used to form 
J1. The data are based on the protocol used by Seeman and Kallenbach to 
characterize, J1.73 The data provides a direct method to compare the mobility of 
immobile hybrid PNA–DNA junctions vs. a DNA control junction (J1) and 
potentially contaminating multi-PNAs. In each gel (Fig. 18 - 20), the single strand 
control (101) is loaded in lane 1; the different single strand combinations are 
loaded in lanes 2–11; the DNA control, J1 is loaded in lane 12, and the hybrid 
PNA–DNA junctions are loaded in lanes 13 and 14. 
 
Figure 18. Formation Controls for 4WJ-PNA1 and b4WJ-PNA1 
Lanes 1-14: 1) 101*, 2) 101*-102, 3) 101*-103, 4) 101*-104, 5) 102-103*, 6) 102-104*, 7) 103-104*, 8) 101*-102-103,      
9) 101*-102-104, 10) 101*-103-104, 11) 102-103-104*, 12) J1(101*), 13) 4WJ-PNA1(103*), and 14) b4WJ-PNA1(103*).  
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Figure 19. Formation Controls for 4WJ-PNA3 and b4WJ-PNA3 
Lanes 1-14: lanes 1-14: 1) 101*, 2) 101*-102, 3) 101*-103, 4) 101*-104, 5) 102-103*, 6) 102-104*, 7) 103-104*, 8) 101*-
102-103, 9) 101*-102-104, 10) 101*-103-104, 11) 102-103 104*, 12) J1(101*), 13) 4WJ-PNA3(101*), and 14) b4WJ-
PNA3(101*). 
 
 
Figure 20. Formation Controls for 4WJ-PNA1,3 and b4WJ-PNA1,3 
Lanes 1-15: lanes 1-14: 1) 101*, 2) 101*-102, 3) 101*-103, 4) 101*-104, 5) 102-103*, 6) 102-104*, 7) 103-104*, 8) 101*-
102-103, 9) 101*-102-104, 10) 101*-103-104, 11) 102-103 104*, 12) J1 (101*), 13) 4WJ-PNA1,3(104*), and 14) b4WJ-
PNA1,3(bf104*).  
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The electrophoretic mobilities of J1 and the hybrid junction bands (Fig. 18 
- 20 lanes 12-14) are significantly reduced compared to bands seen with the 
double and triple DNA strand combinations (Fig. 18 - 20 lanes 2 - 11 ). Double 
and triple strand combinations in lanes 2, 7, 8, 9, and 10 from each analysis 
representing combinations of 101-102, 103-104, 101-102-103, 101-102-104, and 
101-103-104, respectively, display bands that run slower than the 101 strand 
control (lane 1) but faster than the junction bands in lanes 12 - 14. These bands 
likely represent duplex or possibly triplex structures. Fig. 18 - 20 show that none 
of the double and triple strand combinations shown in lanes 2 - 11 form species 
that run with the same mobility as bands representing the 4WJs in lanes 12 - 14. 
These results display indirectly that the duplex and triplex structures do not 
aggregate to form contaminating structures that run with the same 
electrophoretic mobility as immobilized 4WJs. Instead, it seems that immobilized 
junctions merely dissociate to a certain extent during gel analysis. High mobility 
bands seen in lanes 2 - 9 of Fig 17 then represent single strand and duplex 
and/or triplex structures and low mobility bands represent 4WJs.  
3.2 HMGB1 Binding 
EMSAs were used to evaluate the binding affinity of b4WJ-PNA1, b4WJ-
PNA3, 4WJ-PNA1,3 and b4WJ-PNA1,3 toward the recombinant DNA binding 
protein, HMGB1b. Fluorescence binding and analytical ultracentrifugation 
analysis from previous studies have shown that HMGB1b binds J1 with a 
stoichiometry of four to one (4:1), presumably favoring the open configuration.67 
Previous EMSA studies were used to measure the binding constants of 4WJ-
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PNA1 and 4WJ-PNA3 toward HMGB1b.66 Both 4WJ-PNA1 and 4WJ-PNA3 formed 
4:1 complexes that migrate as single bands without intermediate binding species. 
Previous studies suggest that hybrid junction 4WJ-PNA3 binds HMGB1b with a 
nearly identical affinity to J1 (Kd ≈ 6.0 M).66 Previous studies suggest that the 
binding affinity of HMGB1b for 4WJ-PNA1 was only slightly less than that of J1 
(Kd ≈ 16.0 M).66 The current study examines the HMGB1b binding properties of 
four additional hybrid junctions, b4WJ-PNA1, b4WJ-PNA3, 4WJ-PNA1,3, and 
b4WJ-PNA1,3. The DNA overhangs have been truncated from 4WJ-PNA1 and 
4WJ-PNA3 to produce the blunt-ended junctions b4WJ-PNA1 and b4WJ-PNA3, 
respectively. The multi-PNA junctions 4WJ-PNA1,3 and b4WJ-PNA1,3 each 
contain two PNA strands. The b4WJ-PNA1,3 hybrid is the smallest of the 4WJs 
examined, with truncated DNA sequences at the end of each arm. These new 
hybrids were developed in an effort to increase the thermal and nuclease stability 
of 4WJs. However, these changes to the DNA strand sizes and junction PNA 
content may affect HMGB1 binding affinity. EMSAs were used to examine the 
binding affinity of b4WJ-PNA1, b4WJ-PNA3, 4WJ-PNA1,3 and b4WJ-PNA1,3 
toward HMGB1b in order to understand the effects of removing DNA overhangs 
and adding an additional PNA strand on the protein recognition properties of 
hybrid 4WJs toward the recombinant DNA binding protein, HMGB1b. 
The EMSA data is displayed in Fig. 21. Panels A-E represent: J1, b4WJ-
PNA1, b4WJ-PNA3, 4WJ-PNA1,3 and b4WJ-PNA1,3. The protein and junction are 
expressed in terms of molar ratio of protein to junction (P/J). Lane 1 corresponds 
to 0.05 mM of 4WJ, lanes 2-8 represent each 4WJ incubated with each protein at 
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P/J ratios of 3.2:1, 6.4:1, 12.8:1, 25.6:1, 47.8:1, 63.4:1 and 79:1. Fig. 21A shows 
initial binding of HMGB1b to J1 in lane 3 at a ratio of 6.4:1. Complete binding of 
HMGB1b to J1 is achieved by lane 4 at a P/J ratio of 12.8:1. Fig. 21B shows 
HMGB1b binding to b4WJ-PNA1 with affinity similar to J1. Initial binding 
interactions with b4WJ-PNA1 again take place at a P/J ratio of 6.4:1 (lane 3). 
Complete binding of HMGB1b to b4WJ-PNA1 is seen in lane 4 at a P/J ratio of 
12.8:1. In Fig. 21C HMGB1b was shown to bind b4WJ-PNA3 with a slightly lower 
affinity than J1 and b4WJ-PNA1. Initial binding of b4WJ-PNA3 takes place at a 
P/J ratio of 12.8:1 (lane 4), and complete binding of HMGB1b to b4WJ-PNA3 is 
achieved at a P/J ratio of 25.6:1 (lane 5). The multi-PNA hybrids, 4WJ-PNA1,3 
and b4WJ-PNA1,3 are shown in Fig. 21D and E. HMGB1b showed similar binding 
patterns with 4WJ-PNA1,3 and b4WJ-PNA1,3. Both 4WJ-PNA1,3 and b4WJ-PNA1,3 
EMSAs show the appearance of broadened/smeared bands.with increasing 
HMGB1b concentration, indicative of the formation of unstable protein/junction 
complexes that dissociate under experimental conditions. Initial HMGB1b binding 
is evidenced by the appearance of smeared bands at P/J ratios of 12.8:1 for 
4WJ-PNA1,3 (Fig. 21D, lane 5) and 24:1 for b4WJ-PNA1,3 (Fig. 21E, lane 6). The 
smeared bands continue to broaden as the P/J molar ratio increases out to 79:1 
(lane 8) indicating an increase in junction binding. However, complete binding of 
4WJ-PNA1,3 and b4WJ-PNA1,3 is never achieved. 
Previous binding studies show that HMGB1b has a similar binding affinity 
for J1 and hybrid junctions 4WJ-PNA1 and 4WJ-PNA3. The EMSA results of the 
current study suggest that the blunt-ended hybrid junctions b4WJ-PNA1 and 
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b4WJ-PNA3 also bind HMGB1b with a similar affinity to J1. This result suggests 
that truncating the DNA overhangs did not adversely affect the HMGB1b binding 
capacity of hybrid 4WJs, and demonstrates the therapeutic potential of these 
new constructs as ligands for HMGB1. The multi-PNA hybrid junctions, 4WJ-
PNA1,3 and b4WJ-PNA1,3 do not form stable complexes and are not expected to 
be viable therapeutic ligands for HMGB1.  
 
 
Figure 21. EMSA of HMGB1b binding  
 A) J1 and novel hybrid junctions  B) b4WJ-PNA1, C) b4WJ-PNA3, D) 4WJ-PNA1,3 and E) b4WJ-PNA1,3. Lanes 1-8 of each 
panel contain protein/DNA ratios of 1) 0:1, 2)  3.2:1, 3) 6.4:1, 4) 12.8:1, 5)  25.6:1, 6)  47.8:1, 7) 63.4:1 and 8) 79:1, 
respectively. 
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3.3 CD Analysis of Hybrid 4WJs 
B-form and A-from DNA possess different CD spectra. The spectra of B-
form DNA show positive bands at 280nm and negative bands at 250nm that are 
roughly symmetrical.  A-form DNA show a characteristic negative band at 
~205nm and a strong positive band between 260 and 270nm. Fig. 22A and B 
show comparisons of CD spectra of J1 and the hybrid 4WJs in low (0.01mM) and 
high (2mM) concentrations of Mg2+ ion. The 2mM Mg2+ ion concentration was 
chosen to correspond with the high end of the standard ECM Mg2+ ion 
concentration range of 1mM – 2mM.125 CD spectra of the hybrid 4WJs are quite 
different from that of J1. Spectra of the hybrid 4WJs show positive bands 
between 265 and 278nm are blue shifted and lower in intensity compared to 
those of J1. These positive bands displayed a lack of symmetry with negative 
bands centered at 250nm in all hybrid 4WJ spectra. Hybrid junctions also 
showed an intense peak near 205nm under both sets of conditions. The lack of 
symmetry in the bands between 250 and 280nm and the presence of the peaks 
at 205nm are highly indicative of a shift toward more A-form conformation. These 
shifts were more pronounced in the case of the multi PNA constructs.   
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Figure 22. CD spectra of 4WJs in low (~0.01mM) and high (2mM) Mg2+ 
CD spectra highlighting A- and B-form signals for J1 vs. single-PNA and multi-PNA 4WJ in low and high Mg2+. Panel A) 
represents each single- and multi-PNA hybrid vs. J1 in low Mg2+. Panel B) represents each single- and multi-PNA hybrid 
vs. J1 in high Mg2+. 
CD spectra can be used to effectively examine the relative contribution of 
A and B form helical character to the overall spectra. This is done by examining 
signals at 205 and 250nm. The ratio between the magnitudes of the two peaks 
yields the apparent fraction of A and B form helices.78,94,114,115 Fig. 23 shows the 
apparent fraction of A (AFA) and B (AFB) form helices determined for each 
junction in high and low Mg2+. The DNA control J1 displayed AFB values 
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exceeding 0.85 in both low and high Mg2+ denoting its predominantly B-form 
character. 
Hybrid junctions all showed a propensity for higher fractions (0.5-0.95) of 
A-form helices in the absence of Mg2+. Single PNA b4WJs showed a propensity 
for greater B-form character than their full-length counterparts. All single PNA 
hybrids displayed considerable structural sensitivity to Mg2+ concentration. In the 
presence of 2mM Mg2+ all single PNA hybrids shifted to higher AFB with the 
greatest shift seen for b4WJ-PNA3 (0.5 to 0.9 AFB). The multi PNA hybrids 
possessed the highest AFA. The structure of the multi PNA hybrids was largely 
unaffected by Mg2+ concentration, retaining <0.9 AFA under both sets of 
conditions. The signals between 265 nm and 280 nm are excluded because they 
are common to both A- and B-form conformers. The hatched bars represent 
helical fractions calculated in low Mg2+; the solid bars represent fractions 
calculated in high Mg2+.  
 
Figure 23. Apparent fraction of B- and A-form DNA 
(A) B-form DNA and (B) A-form DNA of each junction in low and high Mg2+ 
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The FB value of each single- PNA construct increases in high Mg2+ (solid 
bars); three of four hybrids possess AFB values > 0.5. The secondary structure of 
the PNA3 derived hybrids proved more sensitive to Mg2+ than PNA1 derived 
hybrids, again illustrating the sequence dependence of hybrid structure and 
stability. 4WJ-PNA3 and b4WJ-PNA3 display an approximate 2-fold increase in B-
form content in high Mg2+, with the AFB value for b4WJ-PNA3 being nearly 
identical to J1. The large AFA values (> 0.9) for the multi-PNA hybrids reflect the 
strong A-form CD signature displayed in Fig. 22. Moreover, the structure of the 
multi-PNA junctions showed little sensitivity to Mg2+ concentration in the range 
examined (0.01mM – 2.00mM). 
The CD spectra of the hybrid junctions indicate that the helicies of the 
single-PNA hybrids more closely resemble those of J1 vs. the multi-PNA hybrids. 
The CD wavelength scans suggest that secondary structure of the single-PNA 
hybrids is largely composed of helices that possess A- and B-form 
characteristics. Moreover, the CD spectra clearly show that ionic strength 
strongly influences the secondary structure of the single-PNA hybrid junctions. 
The CD spectra of the single-PNA hybrid junctions display a prominent increase 
in B-form helices upon shifting the ionic strength of the buffer from 0.01mM to 
2.00mM.  Again, these spectra more closely resemble that of the DNA control, 
J1. The CD spectra of the multi-PNA hybrid 4WJs deviate more significantly from 
J1. The multi-PNA hybrids to have larger A-form helical character vs. single-PNA 
hybrids and J1.  Moreover, the secondary structure (A-form content) of the multi-
PNA hybrids are not sensitive to changes in ionic strength.  One plausible 
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explanation for the reduced level of ionic strength sensitivity may be the 
increased hydrophobicity from the additional polyamide PNA peptide back-bone. 
3.4 Thermal Melting Curves and Derivation of Thermodynamic Parameters 
To examine the contribution of the PNA strands to thermal stability and 
further explore the link between ionic strength and junction structure, the effects 
of Mg2+ concentration, end blunting, and PNA strand content on the 
conformational stability of hybrid 4WJs were examined. Thermal denaturation of 
hybrid 4WJs was monitored by CD spectroscopy. Denaturation was examined by 
monitoring the CD signal at the maxima near 280nm as each junction was 
heated from 4°C to 100°C. Denaturation curves were generated by fitting the 
data with a Boltzmann sigmoidal function, and are based on at least three 
independent assays. 
Denaturation curves are shown in Fig. 24A - G. The data has been 
normalized from 0 - 1 to reflect the fraction of intact junction, with 1 being fully 
intact and 0 being fully denatured. Junctions were examined at a concentration of 
2.0μM.The data was fit with a Boltzmann sigmoidal function using GraphPad©. 
Each line represents at least three independent melts.  The denaturation curves 
for J1 in low (0.01mM) and high (2.00mM) Mg2+ ion concentrations, shown in Fig 
24A, have distinct S-shapes. These melting profiles are indicative of cooperative 
two-state transitions from folded junction to unfolded strands.123 J1 denaturation 
curves show estimated onsets of melting near 20°C, evidenced by a rapid 
decrease in slope of the denaturation curve. The slopes of the J1 curves begin to 
rapidly level off near 55°C, indicating J1 is almost fully denatured at this 
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temperature. Full-length single-PNA junctions, 4WJ-PNA1 and 4WJ-PNA3 (Fig. 
24B and D, respectively), show a much earlier onset of melting (<10°C) than the 
other hybrid junctions (20°C -25°C) in both low (0.01mM) and high (2.00mM) 
Mg2+ ion concentrations. 4WJ-PNA1 and 4WJ-PNA3 denaturation curves also 
have more gradual slopes than those of the other junctions, giving them 
comparatively larger melting ranges (≈10°C - 60°C). This may indicate more 
gradual melting transitions or secondary pre-melting transitions for the full-length 
single-PNA junctions.123 The blunt-ended single-PNA junctions, b4WJ-PNA1 and 
b4WJ-PNA3 (Fig. 24C and E, respectively) appear to display clear cooperative 
transitions between folded and unfolded states in low (0.01mM) and high 
(2.00mM) Mg2+ ion concentrations. Both multi-PNA hybrids, 4WJ-PNA1,3 and 
b4WJ-PNA1,3 (Fig. 24F and G, respectively) also seem to display cooperative 
two-state transitions in low (0.01mM) and high (2.00mM) Mg2+ ion 
concentrations. Both 4WJ-PNA1,3 and b4WJ-PNA1,3 showed particularly narrow 
melting ranges (approximately 25°C to 45°C) and sharp transitions compared to 
the other junctions.  
The melt curves show that the blunt-ended single-PNA hybrids and multi-
PNA hybrids undergo sharper and more cooperative melting transitions 
compared to the full-length single-PNA hybrids, suggesting an increase in 
thermal stability. The earlier onset of melting and the more gradual slopes 
suggest the full-length single-PNA hybrids exhibit some form of premelting 
behavior, possibly due to the increased freedom of motion of the DNA 
overhangs.   
 49 
 
Figure 24. Thermal melting curves of 4WJs in low versus high Mg2+  
 (A) J1, (B) 4WJ-PNA1, (C) b4WJ-PNA1, (D) 4WJ-PNA3, (E) b4WJ-PNA3, (F) 4WJ-PNA1,3, and (G) b4WJ-PNA1,3. High 
Mg2+ (2.00mM) conditions are shown with open circles. Low Mg2+ (0.01mM) conditions are shown with solid circles. The 
curves shown are Boltzmann sigmoid fits of the data. All junctions were examined at 2μM concentrations from 4°C to 
100°C. The data shown are based on at least three independent assays. 
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Melting curves were used to generate Tm values for J1 and the hybrid 
junctions. Table 1 shows the Tm values for each junction in low (0.01mM) vs. high 
(2.00mM) Mg2+ ion concentrations and ΔTm from low to high Mg2+ concentration. 
The Tms for the single-PNA junctions and b4WJ-PNA1,3 are higher in the 
presence of 2.00mM Mg2+ compared to 0.01mM Mg2+, suggesting that Mg2+has a 
stabilizing effect on these junctions. For these junctions ΔTms from low to high 
Mg2+ conditions range from 1.10°C (b4WJ-PNA3) to 4.28°C (4WJ-PNA3). The 
multi-PNA junction 4WJ-PNA1,3 showed the opposite affect in the presence of 
2.00mM Mg2+ showing a slight decrease in Tm (ΔTm = -0.55) compared to 
0.01mM Mg2+. For the majority of the junctions examined, the ΔTms for low vs. 
high Mg2+ suggest that hybrid 4WJs are stabilized by the presence of 2.00mM 
Mg2+ ions. This stabilization effect may be attributed to an increase in the 
stabilization of the solvation shell surrounding the junction lattice.104,126  
Table 1  
4WJ Tms in low (0.01mM) and high (2.00mM) Mg2+ 
 
ΔTm values show differences in Tms of each junction in low (0.01mM) vs. high (2mM) Mg
2+ 
 
Junction                  J1              4WJ-PNA1       b4WJ-PNA1      4WJ-PNA3       b4WJ-PNA3      4WJ-PNA1,3      b4WJ-PNA1,3 
Tm (°C) 
low Mg2+ 
Tm (°C) 
high Mg2+ 
ΔTm (°C) 
high - low 
39.47 ±1.03      32.53 ±1.34      32.83 ±0.86      31.47 ±2.25      40.08 ±0.87      35.60 ±0.78      30.94 ±0.63    
40.04 ±1.04      34.00 ±0.87      35.55 ±1.05      35.75 ±1.83      41.18 ±1.21      35.05 ±0.40      32.95 ±0.75    
0.57                  1.47                  2.72                  4.28                  1.10                 -0.55                  2.01 
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The ΔTm values for each hybrid vs. J1 in low (0.01mM) and high (2.00mM) 
Mg2+ ion concentrations are listed in Table 2. The ΔTm values show the majority 
of the hybrid junctions to be slightly less thermally stable than J1 at both high and 
low Mg2+ concentrations. Only b4WJ-PNA3 showed an increase in Tm versus J1 
(ΔTm = 1.14°C in 0.01mM Mg2+ ion concentration and ΔTm = 1.14°C in 2.00mM 
Mg2+ ion concentration). The ΔTm value for each hybrid vs. J1 in 0.01mM Mg2+ 
range from - 8.53°C (b4WJ-PNA1,3) to 0.61°C (b4WJ-PNA3). Upon shifting to 
2mM Mg2+, the ΔTm values of the hybrids vs. J1 range from - 7.09°C (b4WJ-
PNA1,3) to 1.14°C (b4WJ-PNA3). This further illustrates the Mg2+ sensitivity of 
hybrid 4WJs. The increase in Tm of b4WJ-PNA3 compared to J1 indicates that 
addition of PNA strands to the junction lattice is a viable method for increasing 
the thermal stability of 4WJs.  
Table 2  
Hybrid junctions vs. J1 in low (0.01mM) and high (2.00mM) Mg2+ 
 
ΔTm values show differences in Tms of each hybrid vs. J1 
 
 
Junction                  J1              4WJ-PNA1       b4WJ-PNA1      4WJ-PNA3       b4WJ-PNA3      4WJ-PNA1,3      b4WJ-PNA1,3 
Tm (°C) 
low Mg2+ 
Tm (°C) 
high Mg2+ 
ΔTm (°C) 
hybrid - J1 
39.47 ±1.03      32.53 ±1.34      32.83 ±0.86      31.47 ±2.25      40.08 ±0.87      35.60 ±0.78      30.94 ±0.63    
40.04 ±1.04      34.00 ±0.87      35.55 ±1.05      35.75 ±1.83      41.18 ±1.21      35.05 ±0.40      32.95 ±0.75    
   -                   -6.94                 -6.64                  -8.04                 0.61                 -3.87                 -8.53 
ΔTm (°C) 
hybrid - J1 
  -                    -6.04                  -4.49                 -4.29                  1.14                -4.99                 -7.09 
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Table 3  
Full-length junctions vs. blunt-ended junctions in low (0.01mM) and high 
(2.00mM) Mg2+  
 
ΔTm values show differences in Tms of each full-length junction containing overhangs vs. blunt-ended junctions. 
The freedom of motion of the DNA overhangs present in full-length 
junctions 4WJ-PNA1, 4WJ-PNA3, and 4WJ-PNA1,3 may result in structural 
instability of these hybrid junctions. To evaluate the effects of removing DNA 
overhangs, Tm values of full-length junctions were compared to blunt-ended 
junctions. The resulting ΔTms are listed in Table 3. Truncating the overhangs 
increased the Tms of the single-PNA hybrids in both low (0.01mM) and high 
(2.00mM) Mg2+. The junction b4WJ-PNA3 showed the highest ΔTms in both low 
(ΔTm = 8.61°C) and high Mg2+ (ΔTm = 5.43°C). The results for the single-PNA 
hybrids suggest that removal of DNA overhangs produces a stabilizing effect on 
these hybrid junctions. However, a reduction in Tm was observed between the 
full-length multi-PNA hybrid and its blunt-ended counter part. For the multi-PNA 
hybrids, the thermal unfolding data shows the Tm value for b4WJ-PNA1,3 is -
Junction          4WJ-PNA1       b4WJ-PNA1      4WJ-PNA3       b4WJ-PNA3      4WJ-PNA1,3      b4WJ-PNA1,3 
Tm (°C) 
low Mg2+ 
Tm (°C) 
high Mg2+ 
ΔTm (°C) 
blunt-full 
32.53 ±1.34      32.83 ±0.86      31.47 ±2.25      40.08 ±0.87      35.60 ±0.78      30.94 ±0.63    
34.00 ±0.87      35.55 ±1.05      35.75 ±1.83      41.18 ±1.21      35.05 ±0.40      32.95 ±0.75    
   -                    0.30                      -                     8.61                     -                    -4.66 
ΔTm (°C) 
blunt - full 
   -                    1.55                      -                     5.43                     -                    -2.10  
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4.66°C lower than 4WJ-PNA1,3 in low Mg2+ and -2.10°C lower in high Mg2+. The 
reduction in Tm shown for 4WJ-PNA1,3 vs. b4WJ-PNA1,3 may be a result of 
different forces stabilizing the tertiary structure (i.e. stacked-X conformation). The 
increased hydrophobicity imparted by the PNA strands may lead to a stabilization 
from the hydrophobic effect. The DNA overhangs of 4WJ-PNA1,3 may act as a 
negatively charged shell around a more hydrophobic core, ordering the solvent 
cage around 4WJ-PNA1,3 resulting in an increased Tm compared to b4WJ-PNA1,3.     
In order to further examine the temperature- dependent melting behavior 
of 4WJs, the melting curves from Fig. 24 were analyzed for van’t Hoff transition 
enthalpies (ΔHVH). The values of ΔHVH are a function of the equilibrium constant 
(Keq) and calculated from the rate of change in fraction of DNA/PNA strands in 
junction form at the Tms. The melting curves were normalized to produce upper 
and lower baselines of 1 and 0, respectively. The Y-axis then reflects the fraction 
of DNA/PNA strands in junction form as α. Plots of δα /δT vs. T (Fig. 25) were 
produced from the first derivatives of the Boltzmann sigmoidal functions used to 
fit the normalized melting data. The smooth S-shaped melt curves (Fig. 24) 
displayed by most of the hybrid 4WJs indicate a two-state transition between 
folded and unfolded states. However, the unfolding of the full-length single-PNA 
constructs was slow, possibly indicating a gradual transition. The presence of 
multiple peaks or shoulders in the first derivatives of the melting curves would 
indicate a non-cooperative gradual transition. Fig. 25 shows the first derivatives 
of the melting curves have only single peaks giving a clear indication that all 
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hybrid 4WJs undergo a cooperative two state transition upon 
melting.24,26,112,113,123  
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Figure 25. First derivatives of 4WJ melting curves 
The curves show the first derivatives of the Boltzmann sigmoidal functions used to fit the thermal denaturation data. The 
change in fraction of free strands as a function of time (δα /δT) is shown on the Y-axis. Minima represent junction Tms. 
Each junction is shown in low vs. high Mg2+. High Mg2+ (2mM) conditions are shown with a solid line. Low Mg2+ (100μM) 
conditions are shown with a dashed line. 
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Calculation of ΔHVH from the first derivatives of the melting curves was 
done using the three previously discussed methods. Eq. 1, derived from the 
general form of van’t Hoff’s equation, is listed as method 1. The Y values at the 
maxima of the differentiated melting curves are δα /δTm. Eq. 2 was used to 
calculate ΔHVH from the full width of the differentiated melting curve at half height, 
and is listed as method 2. Values for T1 (lower value) and T2 (upper value) were 
taken at (δα /δT)0.5 from the differentiated melting curves. Eq. 3 was used to 
calculate ΔHVH from the half width of the differentiated melting curve at half 
height, and is listed as method 3. The association reaction constants for 
tetramolecular nucleic acid interactions used for the calculation of ΔHVH at the full 
(B) and half-widths (B’) were reported in previous work by Marky and 
Breslauer.123 In this case a molecularity of n=4 yields values of 15.40 for B and 
5.63 for B’.  
Comparisons of the ΔHVH values for J1 vs. each hybrid junction are shown 
in Table 4 for both low and high Mg2+ ion concentrations. Table 4 shows that, at a 
2.00mM Mg2+ ion concentration, ΔHVH values of 4WJ-PNA1 and 4WJ-PNA3, 
decrease by approximately 1.4 to 5.4 kcal/mol compared to J1. These results are 
in line with the Tm results, suggesting that 4WJ-PNA1 and 4WJ-PNA3 are less 
stable than J1 at a 2.00mM Mg2+ ion concentration. At a 0.01mM Mg2+ ion 
concentration ΔHVH values for 4WJ-PNA1 and 4WJ-PNA3 decrease by 0.5 and 
14.8 kcal/mol, respectively, again suggesting a decrease in stability compared to 
J1 in line with the Tm results. At a 0.01 mM Mg2+ ion concentration b4WJ-PNA3 
appears slightly more stable than J1, showing a 3.3 kcal/mol increase in ΔHVH 
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compared to J1. However, at a 2.00 mM Mg2+ ion concentration b4WJ-PNA3 
showed a 4.7 kcal/mol decrease in ΔHVH compared to J1. This is in contrast to 
the Tm comparison between b4WJ-PNA3 and J1, which showed b4WJ-PNA3 to 
have a higher Tm than J1 at a 2.00mM Mg2+ ion concentration and a lower Tm 
than J1 at 0.01mM Mg2+ ion concentration.  
Table 4  
ΔHVH of Hybrid junctions vs. J1 in low (0.01mM) and high (2.00mM) Mg2+ 
 
Values are shown for each junction at low (0.01mM) and high (2.00mM) Mg2+ ion concentrations. 
 
The reduction in ΔHVH shown for the full-length single-PNA junctions 4WJ-
PNA1 and 4WJ-PNA3 compared to J1 may be attributed to destabilizing effects 
from the loss of four DNA base pairs and the increased freedom of motion of the 
unpaired DNA overhangs. The PNA3 constructs 4WJ-PNA3 and b4WJ-PNA3 may 
have lower ΔHVH values than J1 due not only to loss of four base pairs, but also 
to the presence of the three AT pairs at the ends of junction arm III.  The AT pairs 
at the ends of 4WJ-PNA3 and b4WJ-PNA3 are less stable than the GC pairs at 
Junction                  J1              4WJ-PNA1       b4WJ-PNA1      4WJ-PNA3       b4WJ-PNA3      4WJ-PNA1,3      b4WJ-PNA1,3 
ΔHVH  
(kcal/mol) 
low Mg2+ 
ΔHVH  
(kcal/mol) 
high Mg2+ 
42.5 ±6.3           42.0 ±5.7           57.7 ±8.6         27.7 ±3.3          45.8 ±8.6         61.7 ±9.4            53.3 ±7.5    
46.6 ±6.7           41.2 ±5.6           64.3 ±9.3         32.3 ±4.7          41.9 ±6.3        72.2 ±11.5           61.9 ±9.3    
ΔHVH  
(kcal/mol) 
hybrid - J1 
  -                     -5.4                    17.7                 -1.43                 -4.7                 25.6                    15.3 
ΔHVH  
(kcal/mol) 
hybrid - J1 
  -                     -0.5                    15.2               -14.8                    3.3                 19.2                    10.8 
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the ends of J1 and may lead to premature onset of melting and lower ΔHVH 
values. 
Table 4 shows that in both low (0.01mM) and high (2.00mM) Mg2+ ion 
concentrations the ΔHVH values of b4WJ-PNA1, 4WJ-PNA1,3, and b4WJ-PNA1,3 
increase by 10 - 25 kcal/mol compared to J1. This is in contrast to a decrease of 
approximately 4°C - 9°C in the Tms of b4WJ-PNA1, 4WJ-PNA1,3, and b4WJ-
PNA1,3 compared to J1. The decrease in Tm values coupled with an increase in 
ΔHVH values compared to J1 suggests that the b4WJ-PNA1 and the multi-PNA 
hybrids may be more stable than J1 in the lower range of temperatures examined 
(4°C  - 25°C). This is evidenced by the relatively flat upper portion of the melt 
curves between 4°C and 25°C, and the sharp drop in CD signal near the Tms for 
b4WJ-PNA1, 4WJ-PNA1,3, and b4WJ-PNA1,3 (Fig. 24C, F, and G, respectively). 
The melt profile of J1 (Fig. 24A) displays an initial drop in CD signal at a slighltly 
lower temperature (20°C) in comparison to b4WJ-PNA1, 4WJ-PNA1,3, and 
b4WJ-PNA1,3 (25°C), and displays a much more gradual loss of signal.  
More favorable base-stacking interactions from the reduced charge 
repulsion imparted by the PNA1 strand coupled with the stabilizing effect of 
removing DNA overhangs may lead to a higher ΔHVH for b4WJ-PNA1 compared 
to J1. The increase values of ΔHVH shown for the multi-PNA hybrids compared to 
J1 may again be due to more favorable base-stacking interactions. The 
increased flexibility of PNA and the lack of charge repulsion between the DNA 
and PNA strands may allow the multi-PNA hybrids to maximize base-stacking 
interactions of all four arms, producing a stabilizing effect on the helical structure 
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of these junctions at temperatures below 25°C. Alternatively, the multi-PNA 
hybrids may possess a more stable stacked-X structure than the other junctions 
at temperatures below 25°C that must first unfold before denaturation can occur.  
Above 25°C the stabilizing effect of favorable base-stacking interactions or 
stacked-X structure may be overcome by the destabilizing effects of loss of eight 
base pairs compared to J1 and a more disordered solvent cage from the 
increased hydrophobicity imparted by the PNA strands. These combined effects 
may lead to the higher ΔHVH and lower Tms observed for 4WJ-PNA1,3 and b4WJ-
PNA1,3 compared to J1.  
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CHAPTER IV - DISCUSSION AND CONCLUSION 
4.1 Discussion 
The goal of this study was to examine hybrid PNA-DNA 4WJs as possible 
therapeutics to target HMGB1. EMSAs, used to probe binding interactions of 
HMGB1b with hybrid 4WJs, suggest that HMGB1b recognizes single-PNA hybrid 
4WJs, b4WJ-PNA1 and b4WJ-PNA3, with similar affinity to the DNA control, J1 
(Fig. 21B and C) supporting the hypothesis that the DNA-binding cytokine, 
HMGB1, recognizes unnatural nucleic acid substrates. CD, used to examine 
structural differences between hybrid PNA-DNA junctions and pure DNA 
junctions, showed that single-PNA hybrid junctions have a more B-form helical 
character than the multi-PNA hybrids. Together, the EMSA and CD structural 
analysis results suggest that the helical structure of the hybrid 4WJs may be a 
key factor influencing HMGB1b binding affinity. Thermal melting behavior was 
examined via CD to guage the relative stabilities of hybrid PNA-DNA junctions 
compared to pure DNA junctions. The single-PNA hybrid b4WJ-PNA3 showed 
increased Tm compared to J1.  The EMSA and thermal analysis results suggest 
that the single-PNA hybrid b4WJ-PNA3 poseses a similar HMGB1b binding 
affinity and enhanced thermal stability compared to its DNA parent structure J1. 
This suggests that b4WJ-PNA3 may be a suitable therapeutic ligand for HMGB1.  
There are several plausible explanations to explain why HMGB1b 
recognizes certain hybrid 4WJs more readily. Two of the main possibilities are 
linked to:  i) the rotation angle between adjacent helices in the junction lattice 
(Jtwist) and ii) topology (dimensions) of the minor groove of each 4WJ. Previous 
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studies utilizing X-ray crystallography, electrophoresis, FRET and atomic force 
microscopy have shown that the rotation angle (Jtwist) between the two adjacent 
helices of a J1 in the stacked-X form is between 56.5° - 60°.77,96,110,112,113,127 
These Jtwist dimensions presumably facilitate protein recognition by placing the 
junction branch point in a favorable conformation for HMGB1b binding.77,96  We 
suspect that the single-PNA hybrids have a similar Jtwist value to J1 that 
promotes protein binding.  The multi-PNA, however, possess PNA strands that 
represent ~50% of the junction lattice.  In this case, the flexible PNA backbones 
of the multi-PNA hybrids enable the junction lattice to assume Jtwist values that 
are either > or < 56.5° - 60°. As a result, the multi-PNA junctions may adopt 
unfavorable conformations that destabilize HMGB1b binding interactions.  As a 
result, discreet 4:1 complexes do not form. The schematic below (Fig. 26) shows 
a model of the potential binding interactions of HMGB1b with single-PNA (Fig. 
26A) and multi-PNA hybrids (Fig. 26B). I suspect that the Jtwist angles between 
the junction arms of the single-PNA hybrids (Fig. 26A) more closely match the 
60° angles of the DNA control, J1 than do the multi-PNA hybrids. The Jtwist 
angles of the multi-PNA hybrids (Fig. 26B) may deviate to produce more acute or 
obtuse angles that are unfavorable for HMGB1b binding. The reduction in binding 
affinity of HMGB1b toward multi-PNA hybrids seen in the EMSAs (Fig. 21F and 
G) may be due to reduced access to the 4WJ binding sites or additional energy 
differences between unbound and bound 4WJ conformations as a result of 
unfavorable Jtwist angles as illustrated in Fig 26B. Another possible reason for 
the reduced affinity observed between HMGB1b and the multi-PNA hybrids may 
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be the lack of electrostatic interactions between HMGB1b and both PNA 
backbones of these junctions. Additionally, electrostatic interactions between 
positively charged residues along the binding face of HMGB1b and junctions are 
lost from replacement of two sugar/phosphate backbones with uncharged PNAs 
for the multi-PNA 4WJs vs. one for the single-PNA junctions. This 50% reduction 
in backbone charge of the multi-PNA junctions is a likely contributor to the 
reduced affinity shown for HMGB1b in the EMSAs. 
   
Figure 26. Schematic of the effects of changing Jtwist angle on HMGB1 binding. 
With respect to changes in the topology of 4WJs, it is well known that the 
minor groove of A-DNA is broader than B-form DNA.112,126,128 HMGB1b is binds 
within the minor groove of B-DNA.  Presumably, the narrow minor groove of B-
DNA promotes enhanced binding contacts with HMGB1b. Conversely, the hybrid 
4WJs with large fraction of A-form helices (i.e. the multi-PNA junctions) possess 
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broader minor groove dimensions that may reduce contacts with HMGB1b. NMR 
studies of hybrid PNA-DNA duplexes by Eriksson et al. showed these substrates 
to possess characteristics of both A- and B-form DNA.105 In this study, the multi-
PNA hybrid junctions have an approximately 9-fold larger A-form signal at 205 
nM compared to J1.  Although CD does not provide high-resolution data, one 
may surmise that the minor groove dimensions of the helices measured via CD 
have similarities to the known 3-D structures of B- and A-form DNA duplexes.  If 
this is the case, the B-form helices found in J1 have a narrow, shallow minor 
groove topology, while the helices of the hybrid junctions have broader, shallower 
minor grooves intermediate between the topology of A- and B-DNA. Fig. 27 
displays a model of minor groove of B-, B/A, and A-DNA helices.  It is clear that 
B-DNA helices (left panel) have narrow minor groove that may enable proteins 
(presumably HMGB1b) to fit firmly into the groove.  The intermediate structure 
B/A possesses a broader minor groove. I hypothesize that single-PNA structures 
have a minor groove topology that is more similar to the intermediate B/A model.  
Hence, HMGB1b fits firmly into this minor groove and forms discreet 4:1 
complexes similar to J1.  This viewpoint is strengthened by NMR data of PNA-
DNA duplexes; these hybrid PNA-DNA duplexes possess structural features 
intermediate between B- and A-DNA (as shown in Fig. 13).  With respect to the 
multi-PNA hybrids, the CD data shows that these constructs are composed 
largely of A-DNA helices.  Hence, we hypothesize the multi-PNA 4WJs have a 
broader minor groove that is more similar to the A-DNA structure shown in Fig. 
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27 (right panel).  If this is the case, HMB1b does not fit firmly into the minor 
groove. 
 
Figure 27. Space filling 3D models of B-DNA, A-B intermediate DNA, and A-
DNA. 
With respect to the thermostability of hybrid 4WJs vs. J1, thermal melting 
curves (Fig. 24) show that high Mg2+ enhances the stability of five of the six 
hybrid junctions examined (Table 1). The single-PNA hybrids showed a 
noticeable correlation between ionic strength of the solvent (H2O), B-form helical 
content, and Tm. The single-PNA constructs favor B-form helices and possess 
enhanced Tm values in high Mg2+ compared to the multi-PNA junctions. This 
correlation is most evident for b4WJ-PNA3. In the presence of high Mg2+ ion 
concentration, b4WJ-PNA3 possesses higher B-form structure (AFB) and Tm 
values than the DNA control, J1. This effect may again be due to an increase in 
solvent accessibility of Mg2+ for the major grooves of the single-PNA junctions 
reducing charge repulsion between DNA strands and the forming of a more 
organized solvent cage around the junctions.126,129,130 Support for this hypothesis 
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is provided by molecular dynamics (MD) simulations data that show B-DNA 
helices are preferred in high activity solvent(s) due to favorable solvation free 
energy values.126,130 The corresponding solvation free energy values are 
considerably smaller for A-DNA helices.126 The addition of uncharged PNA 
strands to the 4WJs may provide a more hydrophobic environment near their 
complementary DNA strands, reducing the solvation free energies. This results in 
hybrid PNA-DNA 4WJs having more A-form like helices compared to J1, as 
evidenced by the CD results (Fig. 22). In high ionic strength environments (i.e. 
2mM Mg2+), counter ion interactions with the DNA phosphate backbone may be 
strengthened as a result of an increased extent of counter ion condensation in 
the more hydrophobic environment produced by the PNA strands. This is 
evidenced by the increase in Tm for most junctions in 2mM Mg2+ ion 
concentrations (Table 1). 
4.2 Conclusion 
Both single-PNA junctions b4WJ-PNA1 and b4WJ-PNA3 bind HMGB1b 
with similar affinity to pure DNA 4WJs. Replacement of a single J1 strand with a 
PNA did not seem to perturb HMGB1 binding affinity. While the single PNA 
constructs b4WJ-PNA1 and b4WJ-PNA3 were shown to bind HMGB1 with similar 
affinities to that of the parent DNA 4WJ, J1, the multi-PNA junctions showed a 
marked decrease in binding affinity and did not form stable complexes. This may 
be a result of the increased freedom of movement imparted by lack of 
electrostatic repulsion between the DNA strands and the uncharged PNA 
backbone. HMGB1b presumably binds each junction across the branch point. 
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The increased freedom of motion may cause a deviation in the canonical Jtwist 
angle at the branch point and/or a deviation in helical structure. This deviation in 
Jtwist angle may limit access of HMGB1b to the junction branch point or 
decreasing the stability of protein/junction complexes formed between HMGB1b 
and the multi-PNA hybrids. 
The strand replacement and end-blunting strategy showed success in 
increasing the thermal stability of b4WJ-PNA3 vs. J1 under conditions used to 
mimic average ECM Mg2+ ion concentration (i.e. 2.00mM). At a Mg2+ ion 
concentration of 2.00mM, junction b4WJ-PNA3 showed an increase in Tm vs. J1 
of 1.14°C and a large increase in Tm vs. 4WJ-PNA3 of  8.61°C. At a 2.00mM 
Mg2+ ion concentration, single-PNA hybrid junction b4WJ-PNA3, with a Tm of 
41.18°C, was shown to remain stable well above normal body temperature of 
37°C and slightly above high fever temperatures of 40°C. 
The results of this study suggest that hybrid PNA-DNA 4WJs warrant 
further investigation as possible therapeutic agents against unwanted HMGB1 
cytokine activity. Junction b4WJ-PNA3 was shown capable of binding HMGB1b 
with an affinity similar to that of its parent DNA junction and has a Tm well above 
normal body temperature. This study suggests that b4WJ-PNA3 may successfully 
target HMGB1 in vivo and that b4WJ-PNA3 may remain thermally stable in the 
body even at elevated temperatures often associated with inflammation.   
Future plans are to examine the consequences of replacing strands 102 
and 104. In the stacked-X conformation strands 101 and 103 represent the 
continuous strands. Replacing one or both of the crossover strands may have 
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much different effects on local and global conformation as well as junction 
stability. Additionally, studies are planned to examine the serum stability and 
nuclease resistance of hybrid 4WJs. The formulation of junctions containing 
chimeric strands composed of both PNA and DNA is being examined as a 
possible strategy for improving junction stability while maintaining substrate 
viability. 
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CHAPTER V – A POSSIBLE LINK BETWEEN AMINO ACID SELECTIVITY OF 
AMINOACYL-TRNA SYNTHETASES AND GENETIC CODE DEVELOPMENT 
5.1 Synopsis and Hypotheses 
The genetic code is a cornerstone of molecular and cell biology that has 
fascinated scientists for decades. Despite having a clear grasp of the basic 
features of the code, several key questions about its origin remain unsolved.  
Among these questions, the chronology of amino acid (AA) emergence and 
codification are largely unresolved. The objective of Chapters V through VIII is to 
use experimental data to provide evidence to support current genetic code origin 
theories. Aminoacyl-tRNA synthetases (aaRSs), the enzymes responsible for 
production of aminoacyl-tRNAs (aa-tRNAs) in the first step of protein translation, 
are used to perform a selection survey of the 20 natural AAs. Several previous 
studies have suggested that aaRSs are among the oldest families of proteins.131-
134 It has also been suggested that ancestral aaRSs arose during a period of an 
incomplete genetic code (i.e. fewer than 20 AAs) and initially had little AA 
specificity.131,134 These suppositions imply that ancestral aaRSs initially 
developed specificity toward an incomplete or primitive set of AAs. I hypothesize 
that extant aaRSs may retain a selection preference for the substrates of 
their ancestors and that the pool of AAs selected by multiple aaRSs 
represent an early set AAs used in primitive translation.  
In this study, a radiometric assay is used to probe for an AA activation 
imprint (i.e. a selection preference) that is inherent to certain AAs. Using 
experimental techniques focused on elucidating connections between AAs and 
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extant aaRSs may provide novel insight into the process of genetic code 
development. By examining AA selection in the form of misactivation profiles we 
will provide empirical evidence to support a chronology of AA codification. Fig. 28 
shows the two-step synthesis of aa-tRNAs. In Fig. 28 step 1 an AA and a 
molecule of ATP react to form an aminoacyl-adenylate (AA-AMP) with release of 
a diphosphate (PPi). In Fig 28 step 2 the AA moiety of the AA-AMP is transferred 
to a tRNA to form an aa-tRNA. This study focuses solely upon the activation 
reaction shown in step 1 of Fig. 28 and examines the AA discriminating ability of 
each aaRS. The omission of tRNAs provided an opportunity to examine if certain 
AAs are structurally and/or chemically predisposed to reacting with aaRSs. 
Moreover, these investigations revealed potential biosynthetic imprints between 
AAs and aaRSs in the form of selection preferences, that exist in the absence of 
tRNAs, and suggest a relationship between aaRS specificity and AA biosynthesis 
and codification. These findings were compared to genetic code origin studies 
examining AA abundance in early Earth simulations135-138 and meteorites139-142, 
physiochemical properties of AAs143-145, and AA biosynthetic pathways146-149.    
 
Figure 28. A schematic of the aaRS catalyzed aminoacylation reaction  
Step 1 shows the activation of an AA to produce AA-AMP. Step 2 shows the charging of the AA moiety of the AA-AMP to 
a tRNA to produce an aa-tRNA  
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5.2 Code Origin Theories 
5.2.1 Connections between AA Emergence and the Early Earth 
The original simulated primitive earth experiments performed by Miller and 
Urey reportedly produced a variety of organic compounds including AAs such as: 
Ala, Gly, Val, Asp, and Glu.136 The Miller-Urey experiments have been rigorously 
scrutinized and modified to yield similar results under a wide range of possible 
conditions.135,137,138,150-152 The original experiments used electric discharges on a 
mixture of hydrogen (H2), H2O, methane (CH4), and ammonia (NH3) to produce 
organic compounds.136,150 Subsequent experiments incorporated other gases 
such as carbon dioxide (CO2), nitrogen (N2)137,150, and hydrogen sulfide (H2S)151 
and an aspirator to inject steam138. These simulated primitive earth experiments 
have produced a variety of organic compounds, including simple AAs. The 
combined results of four such analyses are shown in Table 5.135,137,138,150 
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Table 5  
Prebiotic AAs produced in early Earth simulations  
 
AAs are listed according to the highest relative abundance compared to Gly (Gly = 100)135,137,138,150. 
Many of the same organic compounds produced in early Earth simulations 
have also been found in studies of carbonaceous meteorite compositions. 
Studies examining the compositions of carbonaceous meteorites have shown 
them to be rich sources of organic compounds, including a large number of AAs. 
The Murchison139,141, Orgueil140, and Murray142 are well studied carbonaceous 
meteorites shown to contain many of the same canonical proteinacious AAs seen 
in the early Earth simulations including Gly, Ala, Val, Pro, Ser, Asp, and Glu. A 
list of AAs found in examinations of these meteorites is shown in Table 6.139-142 
Early Earth simulations and meteorite examinations provide evidence for the 
existence of prebiotic AA sources from which a primitive translation system could 
be built upon. The identification of proteinacious AAs in early Earth simulations 
and meteorite examinations provides evidence for the early availability of these 
Relative	Abundance							
(Gly	=	100)
Relative	Abundance							
(Gly	=	100)
a Glycine 100 a N-isopropyl	glycine 0.5
a Alanine 180 a N-ethyl-β-alanine 0.5
a α-Amino-n-btyric	acid 61 a Isoserine 1.2
a α-Hydroxy-γ-amino	butyric	acid 17 b Isovaline 0.99
a Norvaline 14 c α-Amino-n-heptanoic	acid 0.3
a Sarcosine 12.5 a Proline 0.3
a Aspartic	acid 7.7 a Threonine 0.2
a α,γ-diaminobutyric	acid 7.6 a Allothreonine 0.2
a α-Aminoisobutyric	acid 7 a β-Amino-n-butyric	acid 0.1
a N-ethyl	glycine 6.8 a β-Aminoisobutyric	acid 0.1
a Valine 4.4 c Methionine 0.1
a β-Alanine 4.3 a N-ethyl	alanine <0.05
a N-methyl	alanine 3.4 b β-Hydroxy	aspartic	acid 0.013
a Leucine 2.6 a Pipecolic	acid 0.01
a Glutamic	acid 1.7 d Ethionine 0.01
a α,β-diaminopropionic	acid 1.5 a Ornithine <0.01
a Alloisoleucine 1.2 a Lysine <0.01
a Serine 1.1 a t-Leucine <0.005
a Isoleucine 1.1 b 2-Methyl	serine 0.0016
a Norleucine 1	-	4 d Methionine	sulfoxide <0.001
b Isoserine 2 b α-amino	adipic	acid 0.00038
a α-Methyl-α-amino-n-butyric	acid	(isovaline) 1 b Homoserine 0.00034
a N-methyl-β-alanine 1.0 b 2-methyl	glutamic	acid 0.00024
a γ-Aminobutyric	acid 0.5 b Phenylalanine 0.0002
c Homocysteine 0.5 d Methionine	sulfone <0.0002
a N-propyl	glycine 0.5 d S-Methylcysteine <0.0002
Amino	Acid	identified	in	Early	Earth	
Simulations
Amino	Acid	identified	in	Early	Earth	
Simulations
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AAs, but does not identify them as early coded AAs. However, studies examining 
genetic code origins often point to many of the AAs identified in these early Earth 
simulations and meteorite examinations as early coded AAs.147-149,153-162 
Table 6  
AAs identified in carbonaceous meteorites 
 
All studies employed mass spec coupled GC to examine material from the inner portion of fragments from each meteorite. 
Amino acids denoted with an a or b were also found in the Orguil and Murray meteorites, respectively 139-142. 
5.2.2 Connections between AA Emergence and the Coevolution Theory (CET) 
There are a many theories to explain the establishment of the genetic 
code, some of the most notable are:  the coevolution theory (CET)147-149,153,155, 
the stereochemical hypothesis157,163,164 and error minimization hypothesis 
158,159,165. These theories are not mutually exclusive and each supposition likely 
played a role in the formation of the genetic code.149,153,154  
The CET predicts that the structure of the genetic code is an imprint of 
these biosynthetic pathways and the precursor product relationships between 
AAs.147 The CET assumes that the genetic code was initially comprised of a 
1,2-methyl	aspartic	acid 3-amino-2-ethylpropanoic	acid b Leucine
2-Amino-2-ethyl-3-methylbutanoic	acid 3-amino-2-methylbutanoic	acid Norleucine
2-amino-2-ethylbutyric	acid 3-amino-2,2-dimethylpropanoic	acid Norvaline
2-amino-2-ethylpentanoic	acid 3-aminopentanoic	acid a,b Proline
2-amino-2-methylhexanoic	acid 3,3	methyl	aspartic	acid Pseudoleucine
2-amino-2,3-dimethylbutyric	acid 4-amino-2-methylbutanoic	acid a Sacrosine
2-amino-2,3-dimethylpentanoic	acid 4-amino-3-methylbutanoic	acid b Serine
2-amino-2,3,3-trimethylbutanoic	acid 4-aminopentanoic	acid b Threonine
2-amino-2,4-dimethylpentanoic	acid a,b Alanine a,b Valine
2-amino-3-ethylpentanoic	acid allo-2-amino-3,4-dimethylpentanoic	acid α-Amino-n-butyric	acid
2-amino-3-methylhexanoic	acid allo-3-amino-2-methylbutanoic	acid a α-Aminoisobutyric	acid
2-amino-3,3-dimethylpentanoic	acid allo-3-methyl	aspartic	acid a,b β-Alanine
2-amino-3,4-dimethylpentanoic	acid b allo-Isoleucine a β-Amino-n-butyric	acid
2-amino-4-methylhexanoic	acid a,b Aspartic	acid a β-Aminobutyric	acid
2-amino-4,4-dimethylpentanoic	acid Cycloleucine β-Aminoisobutyric	acid
2-amino-5-methylhexanoic	acid Glutamic	acid a γ-Aminobutyric	acid
2-aminoheptanoic	acid a,b Glycine δ-aminovaleric	acid
2-methyl	glutamic	acid b Isoleucine ε-aminocaporic	acid
2-methylnorvaline Isovaline
Amino	Acid	identified	in	Carbonaceous	Meteorites
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smaller set of precursor AAs (phase 1 AAs) encoded by proto-tRNAs.  As 
primitive biosynthetic pathways became more complex, the evolution of 
precursor AAs to product AAs (phase 2 AAs) was facilitated by these proto-
tRNAs.147-149,153 Genetic code structure then becomes a consequence of 
precursor AAs conceding codons to product AAs. Support for this theory lays in 
the extant precursor/product relationships of AAs and the similarity of their 
codons.147 Figure Fig. 29 shows a proposed evolutionary map of the genetic 
code development with arrows denoting extant AA precursor/product 
relationships (single-headed arrows) and interconversion relationships (double-
headed arrows).147 Codons shown in solid boxes correspond to the extant use in 
the genetic code. Codons in the dotted boxes for Glu and Asp were presumably 
conceded to product Gln and Asn in the later stages of codon assignment. The 
codons of each precursor/product pair are contiguous, differing by only a single 
nucleotide. This mechanism of codon assignment proposed in the CET assumes 
that primordial AAs each occupied continuous regions of the genetic code and 
that codons from this region were conceded to product AAs consistent with the 
observed contiguity of precursor AA and product AA codons.147-149 From the 
biosynthetic and codon relationships shown in Fig. 29, a set of central AAs 
emerges from which all others seemingly evolved and allows the generation of a 
basic chronology of AA codification. This set of seven precursor AAs comprised 
of Glu, Asp, Ala, Ser, Gly, Phe, and Val is presumed by the CET to be the 
earliest set of coded AAs. These AAs are found in relatively high abundance in 
early Earth and meteorite studies giving support to their “early” status.  
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Figure 29. Codon evolution map proposed in the coevolutionary theory.  
From “A co-evolutiontheory of the genetic code,” by Wong 1975, Proc. Nat. Acad. Sci. 72, 1909-1912. Copyright 1975 by 
Proc. Nat. Acad. Sci. Reprinted with permission of the author.147 
5.2.3 Connections between AA Emergence and AA Biosynthetic Pathways 
The investigation of AA biosynthetic pathways has been used to make 
inferences of the relative ages of AAs and aaRSs.  It has been proposed that 
class II aaRSs and their respective AAs are, as a group, more ancient than class 
I aaRSs and AAs.146 This proposal was based on the AA precursor/product 
relationships and distances from the glycolysis pathway, pentose pathway, and 
citric acid cycle. Fig. 30 shows a schematic of the AA biosynthetic pathways 
showing the AAs and their respective codons. AAs specific to class I aaRSs are 
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shown in white and AAs specific to class II aaRSs are shown in grey. While it is 
true that a higher number of class II specific AAs occupy interior nodes of the 
diagram, several of the class I AAs occupy positions very close to the glycolysis 
pathway and citric acid cycle. Also, the class I AA Glu is an important precursor 
in the biosynthesis of Pro, a class II AA. Though the primary goal of this previous 
AA biosynthetic pathway study was to examine the relative ages of the aaRS 
classes, it also provided insight into the chronology of AAs. Fig. 30 illustrates the 
extant precursor/product relationships between AAs and shows their proximity to 
glycolysis, the pentose phosphate pathway, and the citric acid cycle. The extant 
machinery involved in these biosynthetic pathways is undoubtedly quite different 
from that found in early metabolisms. However, the precursor/product 
relationships of the AAs may be an artifact of an early metabolic system.  The 
precursor product relationships shown in Fig. 30  were used to produce a three 
stage chronology of AA codification with Ala, Val, Gly, Ser, Asp, and Glu as more 
ancient; Asn, Thr, Gln, and Pro at an intermediary stage; and Leu, Phe, Tyr, Trp, 
His, Cys, Met, Lys, Ile, and Arg as more recent.146 
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Figure 30. AA biosynthetic pathways  
From “Amino acid biogenisis, evolution of the genetic code and aminoacyl-tRNA synthetases,” by Klipcan et. al.2004. J. 
Theor. Biol. 228, 389-396. Copyright 2004 by Elsevier. Reprinted with permission of the author.146 
5.2.4 Connections between AA Emergence and AA Physiochemical Properties 
Studies examining physiochemical properties of AAs have revealed AA 
stability, polarity, and complexity as factors that correlate strongly with previously 
discussed code origin theories.143-145 One study compared the free energies of 
the 20 natural AAs to sets of corresponding isomers.166 Comparing the free 
energies of formation of the 20 natural AAs to one another showed a set of 
particularly stable AAs (Gly, Ala, Ser, Pro, Val, Thr, Asp, and Glu) that largely 
correspond to the set considered ancient by early Earth simulations, meteorite 
studies, and the CET. Larger AAs His, Phe, Arg, Tyr, and Trp were shown to be 
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the least stable in terms of free energy of formation.166 Another study examined a 
set of 40 criteria and hypotheses associated with genetic code development.144 
This study identified thermal stability of codon-anticodon interactions, codon 
complementarities, abiotic origin, and AA size/complexity as major factors that 
correlate with AA age. This study was used to produce a chronological ranking of 
AAs from earliest to late as follows Gly/Ala, Val/Asp, Pro, Ser, Glu/Leu, Thr, Arg, 
Asn, Lys, Gln, Ile, Cys, His, Phe, Met, Tyr, Trp.144  
All of the theories discussed here assume a gradual progression of 
genetic code development.  During this period, codons would not have been 
specific but instead coded for a set of related AAs producing a non-degenerate 
but functional code. The presence of a primitive code, even an ambiguous code 
with a smaller set of AAs, suggests the presence of primitive proteins.167,168 The 
near ubiquitous nature of aaRSs throughout the three kingdoms of life suggests 
they are very ancient. If aaRS ancestors existed during the period of this primitive 
code, it is plausible that aaRSs may have played a role in AA codification. It is 
conceivable that extant aaRS retain recognition features from this era that will be 
evident in the selection preference for the prebiotic AAs identified in the early 
Earth simulations and meteorite studies. 
5.3 Aminoacyl tRNA-Synthetases (aaRSs) 
5.3.1 Aminoacyl-tRNA Synthesis 
AaRSs are highly specific enzymes that are sentinels of the genetic code. 
Researchers have defined a clear two-step mechanism to describe the role of 
aaRSs in the selection and subsequent attachment of AAs onto their cognate 
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tRNA.  The reaction mechanisms for activation and tRNA charging are displayed 
in Fig. 31.  In the first step (Fig 31A), an aaRS transfers AMP (from ATP) onto an 
AA to form a highly energetic mixed anhydride AA-AMP.  Next, the aaRSs 
attaches the adenylate to the 3’ terminal adenosine of a tRNA. The class II 
aaRSs attach the AA directly to the 3’ hydroxyl (Fig 31C). Class I aaRSs initially 
attach AAs to the 2’ hydroxyl (Fig. 31B), followed by transesterification to the 3’ 
hydroxyl (Fig 31D). In vitro studies have shown that aaRSs possess a 
discrimination factor of 200 – 10,000 during activation; the stringency factor 
increases to > 10,000 during charging.169,170 
  
Figure 31. Aminoacyl-tRNA synthesis 
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Two step reaction: (A) Aminoacyl-adenylate formation (B) Transfer of the activated amino acid to the tRNA 3’-CCA 
terminus 2’-OH by Class I synthetase. C) Transfer of the activated amino acid to the tRNA 3’-CCA terminus 3’-OH by 
Class II. D) 2’-aminoacyl esters undergo a transesterification to the 3’-OH of tRNA.  
5.3.2 aaRSs Role in Genetic Code Development 
It has been suggested that ancestral aaRSs were initially tasked with 
enhancing charging rates in primitive translation with little specificity toward a 
particular amino acid.165,171,172 Under this assumption aaRS development could 
have followed two possible scenarios: i) aaRSs developed AA specificity in the 
presence the genetic code in its current form ii) aaRS specificity coevolved with 
the genetic code. The first scenario implies that a fully-fledged genetic code 
existed in an RNA based translation system prior to the advent of peptides that 
assisted in RNA charging (proto-aaRSs). The second scenario implies the 
existence of a primitive genetic code, similar to the operational codes proposed 
by Schimmel et. al.168 and Rodin et. al.167,173,174, capable of producing functional 
peptides. Further more, it implies that aaRSs were present during the period of 
code expansion and/or ambiguity reduction. Under this second scenario, aaRSs 
may have played a role in determining the structure of the genetic code. This 
may be observable in the interactions between extant aaRSs and AAs, 
specifically in the preferential selection (i.e. misactivation) of more ancient AAs 
by extant aaRSs.  Here, AA misactivation profiles are compared with AA 
chronologies based on:  AA abundance in early Earth simulations150, AA 
biosynthetic pathways147, and physiochemical properties of AAs and 
codons/anticodons144. I hypothesize that extant aaRS will show a selection 
preference for the prebiotic AAs identified in the early Earth simulations and 
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meteorite studies, and for the precursor AAs identified in the AA biosynthesis 
study and CET. 
5.3.3 Classes of aaRSs 
The structures of aaRSs are separated by the different dinucleotide 
binding domains of their active sites.134,175-178 The aaRSs from E. coli are listed in 
Table 7; each sub-class is color-coded.  The majority of bacterial class I aaRSs 
are monomeric with the exception of TrpRS and TyrRS; these synthetases are 
dimers composed of identical subunits (2 dimers).177,179,180 The majority of 
bacterial class II synthetases are 2 dimers, with the exception of GlyRS, PheRS, 
and AlaRS. GlyRS and PheRS are 22 tetramers while AlaRS is an 4 
tetramer.179,181,182 Fig. 32A and B display the crystal structures of the class I 
synthetase GlnRS and class II synthetase AspRS from E .coli. The monomeric 
structure of GlnRS183 and dimeric structure of AspRS184 are typical of each class 
of synthetase.  
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Table 7  
The Aminoacyl-tRNA Synthetases of E. coli 
 
 
 
Figure 32. Crystal structures of class I and II aminoacyl-tRNA synthetases  
A) X-ray crystal structure of the monomeric Class I synthetase GlnRS at a resolution of 2.6 Å [PDB: 1NYL]183.  B) X-ray 
crystal structure of the Class II synthetase AspRS 2 dimer at a resolution of 2.7 Å [PDB: 1EQR]
184.  
5.3.3.1 Class I aaRSs. Class I synthetases contain a Rossmann fold 
nucleotide binding domain within their active sites.179,180,182 A Rossmann fold 
is composed of two alternating ---- structural motifs that form a parallel -
 
Class I Class II 
aaRS Sub-class Structure aaRS Sub-class Structure 
ArgRS Ia a AlaRS IIa a4 
CysRS Ia a ProRS IIa a2 
IleRS Ia a SerRS IIa a2 
LeuRS Ia a ThrRS IIa a2 
MetRS Ia a HisRS IIa a2 
ValRS Ia a GlyRS IIb a2b2 
GluRS Ib a AsnRS IIb a2 
GlnRS Ib a AspRS IIb a2 
TyrRS Ic a2 LysRS IIb a2 
TrpRS Ic a2 PheRS IIc a2b2 
A B 
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sheet. In aaRSs the fold is slightly altered substituting two ---- motifs 
instead.180 The Rossmann fold domains of most class I synthetases contain two 
characteristic motifs (KMSKS and HIGH).179,185 The KMSKS and HIGH motifs are 
named for their amino acid sequences. The KMSKS and HIGH motifs have been 
implicated in the stabilization of the aminoacyl adenylate.179,185 Certain class I 
synthetases contain one or two large connective peptide (CP) insertion domains 
(CP1 and CP2) that bisect the Rossmann fold domains, thought to participate in 
editing function.186,187 Fig. 33 shows the Rossmann fold of GlnRS from E.coli with 
the HIGH and KMSKS motifs are highlighted in green and red.183 The CP1 
insertion domain of GlnRS is highlighted in purple.  
 
Figure 33. Class I Rossmann Fold of GlnRS from E.coli 
 X-ray crystal structure of the class I Rossmann Fold of GlnRS from E.coli at a resolution of 2.6 Å. The HIGH motif is 
shown in green, the MSK motif is shown in red, and the CP1 insertion domain is shown in purple [PDB: 1NYL]
183. 
 83 
5.3.3.2 Class II aaRSs.The structure of class II aaRSs is more varied; 
these enzymes contain an atypical anti-parallel -fold nucleotide-binding domain 
and three conserved structural motifs.181,182,188,189  Fig. 34 displays these 
structural features for AspRS from E. coli.184  Motifs 1, 2, and 3 are highlighted 
in red, green, and blue. Each motif has been shown to facilitate the assembly of 
the dimer interface and ATP binding site.181,182,188,189 Motif 1 (red) is composed of 
a long α-helix and a short β-strand; motif 2 (green) comprises the first two 
strands of the anti-parallel β-sheet nucleotide-binding domain and motif 3 (blue) 
contains the central strand of the anti-parallel β-sheet followed by a short helix. 
   
Figure 34. Class II Beta Fold of AspRS from E. coli  
X-ray crystal structure of the class II Beta Fold of AspRS from E. coli at a resolution of 2.7 Å. Motif 1 is shown in red, Motif 
2 is shown in green, and Motif 3 is shown in blue[PDB: 1EQR]184 
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Fig. 35 shows a 3 dimensional view of the L-shaped structure tRNAPhe 
from yeast.190 Evidence from crystal structures containing tRNA shows a possible 
correlation in the way each class of aaRS approaches the tRNA acceptor 
stem.191,192 Class I aaRSs approach from the minor groove side leaving the 
variable loop (Fig. 35 shown in orange) facing away from the binding site and 
toward the solvent.  Class II aaRSs, on the other hand, approach the major 
groove side resulting in the variable loop facing toward the binding pocket.  
 
Figure 35. An X-ray crystal structure of  tRNAPhe from yeast  
An X-ray crystal structure of  tRNAPhe from yeast at a resolution of 1.93 Å. The acceptor stem is shown in red. The T loop 
is shown in green. The D loop is shown in purple. The variable loop is shown in orange. The anticodon loop is shown in 
blue with the GmAA anticodon in yellow. [PDB: 1EHZ]
190.  
While the amino acid and nucleotide binding strategies are fairly well 
conserved among each class of aaRS, tRNA binding relies on a more 
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complicated set of tRNA structural and chemical features termed identity 
elements that seem to be unique to each aaRS.177,191-194 Each tRNA contains a 
specific set of identity elements.192 Identity elements are a set of tRNA bases that 
are required for recognition by its corresponding aaRS. The primary tRNA 
identity elements for all 20 aaRSs from various species have been established 
using studies involving site-directed mutagenesis of tRNAs.191-193 A list of the 
identity elements found in E. coli tRNAs is shown in Table 8.193 The most 
common identity elements are found in the acceptor stem and anticodon loop 
(blue and yellow, Fig. 35), but nucleotide residues in the D stem (purple Fig. 35), 
T loop (green, Fig. 35), and variable arm have also been shown to be strong 
determinants. Several modified bases present in various tRNAs at different 
locations have also been established as vital to cognate tRNA 
recognition.191,193,194  
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Table 8  
Known identity elements of E. coli tRNAs 
Identity Elements of E. coli 
tRNAs 
 
tRNA tRNA Domain 
 Acceptor Stem Anticodon Loop Other 
Val A73, G3:C70 
U4:A69 
A35, C36  
Ile A73, C4:G69 L/G34, A35, U36, 
t6A37, A38 
U12:A23, C29:G41 
Leu A73  U8A14 
Met A73, U4, A69, 
A5:U68 
C34, A35, U36  
Cys U73, G2:C71, 
C3:G70 
G34, C35, A36 G15G48, 
A13A22 
Tyr A73 U35  
Trp G73, A1:U72, 
G2:C71, G3:C70 
C34, C35, A36  
Glu G1:C72, U2:A71 U34, U35, A37 U11:A24, U13:G22-
A46, Δ47 
Gln G73, U1:A72, 
G2:C71, G3:C70 
Y34, U35, G36, 
A37, U38 
G10 
Arg A/G73 C35, U/G36 A20 
Ser G73, C72, G2:C71, 
A3:U70, C11:G24, 
R4:Y69 
 C11:G24 
Thr G1:C72, C2:G71 G34, G35, U36  
Pro A73, G72 G35, G36 G15C48 
Gly U73, G1:C72, 
C2:G71, G3:C70 
C35, C36  
His C73, G1 Anticodon  
Asp G73, G2:C71 G34, U35, C36, 
C38 
G10 
Lys A73 U34, U35, U36, 
(mnm5s2U)34 
 
Asn G73 G34, U35, U36  
Phe A73 G34, A35, A36, 
G27:C43, G28:C42 
U20, G44, U45, 
U59, U60 
Ala A73, G2:C71, 
G3U70, G4:C69 
 G20 
X:Y denotes standard Watson-Crick base pairing, XY denotes non-Watson-Crick base pairing, X/Y denotes that either 
base can occupy this position, Δ denotes the absence of a residue, L denotes Lysidine, R denotes a purine, Y denotes a 
pyrimidine, t6A is threonylcarbamoyl adenosine, mnm5s2U is 5-methylamino-methyl 2-thiouridine.184,192,193,195,196 
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5.3.4 Fidelity of aaRSs 
The aaRSs are capable of selecting their cognate amino acid from a 
cellular pool of many chemically/structurally similar molecules with high 
efficiency, producing mischarging rates of <10-5 errors per charging event.170,197-
199 Although initial selectivity plays a major role in excluding non-cognate amino 
acids, in most cases initial screenings event do not prevent production of 
misactivated adenylates. Editing functions that hydrolyze misactivated or 
misacylated products supplement substrate selectivity.169,200-204  
The double sieve model is widely accepted as the model to describe the 
high fidelity of AA activation and tRNA charging.200,203,205 The model proposes 
the existence of secondary active sites capable of expelling non-cognate 
substrates that subvert the primary active site. Many aaRSs can expel 
misactivated AAs before they are charged onto tRNAs – a process referred to as 
pre-transfer editing.201-203,206,207 Many aaRSs are also capable of expelling 
misacylated tRNAs – a process referred to as post-transfer editing.201,203,207  Pre-
transfer editing can act in a tRNA independent or tRNA dependent manner to 
expel misactivated AAs. Post-transfer editing mechanisms require tRNA to 
initiate editing or removal of misacylated AAs from non-cognate tRNAs.   
As stated earlier, the initial selectivity of AAs by aaRSs in the activation 
step of aa-tRNA synthesis is the focus of this study.  This allows us to determine 
if certain AAs are structurally or chemically predisposed to reacting with aaRSs.  
AAs that are selected by the largest number of aaRSs presumably possess a 
biological imprint that suggests this pool of AAs is more ancient AAs.  Finally, we 
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compare are AA lineage to those from:  early Earth simulations, meteorite 
composition, the coevolution theory, and AA biosynthetic pathways.  
5.4 Radiometric Amino Acid Activation Assay 
Several radiometric assays have been developed that provide the 
sensitivity and reliability required for an accurate assessment of enzymatic amino 
acid activation and tRNA aminoacylation.208-211 Assays that use [3H] or [14C] 
labeled amino acids and [32P] labeled tRNAs have shown great success in 
measuring steady state and pre-steady state kinetics of AA activation and tRNA 
charging.208-211 However, these techniques have drawbacks.  Assays that rely on 
the radiolabeled amino acid or tRNA to be captured on filter paper or charcoal 
are prone to error from product loss on the filters or during washing.202,208,211 
Moreover, laborious washing steps are required, resulting in low throughput.  
Determining the fraction of activated or aminoacylated product also requires 
knowing the aliquot size and quantum efficiency of the scintillation counter on the 
filter medium.  Moreover, prohibitive levels of [3H] or [14C] labeled amino acids 
are required to investigate aaRSs that possess low KM values (high binding 
affinity) toward their cognate AA.202,208,211 
More recently, sensitive and straightforward assays have been developed 
that use [-32P]ATP as a label to monitor activation.208 Fig. 36 shows the 
potential pathways of the radiolabel during activation (shown in red). In Step 1 
the ATP is esterified to an amino acid to produce an AA-AM[32P]. Step 2 shows 
tRNA independent pre-transfer editing of the resulting AA-AMP to yield the free 
amino acid and AMP. Using [-32P]ATP allows direct monitoring of ATP, AMP, 
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and AA-AMP being consumed or generated in a typical reaction. Products are 
separated using thin layer chromatography (TLC), and can be viewed and 
measured with the aid of phosphor imaging tools. Compared to other radiometric 
methods this process requires fewer steps, employs a much more efficient 
means of product separation, and can also been scaled up using a 96 well-plate 
format for higher throughput.208 
 
Figure 36. Possible pathways of the activation reaction  
Step 1 shows activation of an AA to form AA-AMP. Step 2 illustrates tRNA independent pre-transfer editing resulting in the 
AA-AMP.  
An illustration of the TLC separation pattern is presented in Fig. 37. The 
top spot corresponds to AA-AMP, the middle spot corresponds to AMP, and the 
bottom spot corresponds to unreacted ATP. The presence of activation is 
characterized by the appearance of AA-AMP with signal intensity above that of a 
negative control containing no AA. As shown in Fig. 37 (inset), AA-AMP 
concentration can be calculated by dividing the AA-AMP signal by the total signal 
to find the percentage of ATP converted to AA-AMP (%AA-AMP) and multiplying 
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this percentage by the amount of ATP in the assay. This alleviates the need for 
many of the calculations required when using a scintillation counter (i.e quantum 
efficiency calculations and decay corrections). 
 
  
Figure 37. Radiometric activation assay  
Top Left) Basic activation reaction showing the alpha-[32P] radio label.  Bottom Left) Equation used to calculate %AA-
AMP.  Right) TLC image of activation showing separation of AA-AMP, AMP, and ATP.  
 
 
 
 
 
 
% AA-AMP =               AA-AMP               x  100.  
              (AA-AMP + AMP + ATP) 
   AA-AMP nM =  %  AA-AMP × ATPTot (nM) 
Amino	acid	 α-P32	ATP	
E.	Coli	
aaRS	 Aminoacyl	adenylate	
AA-AMP	
Pyrophosphate	
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CHAPTER VI - MATERIALS AND METHODS 
6.1 Radiometric Assays 
6.1.1. Strategy to Identification of Preferentially Activated AAs 
Each aaRS was initially examined with its cognate AA as a positive control 
and with no AA as a negative control. In order to increase throughput, the α-
[P32]ATP assay was initially used to measure the activation of L-AAs in subsets 
or groups. Each group was incubated with an individual aaRSs. Subsets showing 
AA-AMP production were investigated further. Each AA from subsets showing 
activation was assayed individually to determine which AAs are activated. Each 
AA subset was grouped according to structural and chemical similarity as shown 
in Table 9.  
6.1.2. AA Classification: 
Groups were classified based upon the chemical composition of their 
respective R-groups (Table 9). Group one was composed of aliphatic R-groups 
(Ala, Gly, Ile, Leu and Val); group two contained amine and carboxamide R-
groups (Arg, Asn, Gln and Lys); group three contained carboxyl R-groups (Asp 
and Glu); group four contained hydroxyl R-groups (Ser and Thr); group five 
contained aromatic R-groups (Phe and Trp); group six contained 
sulfhydryl/methyl sulfide R-groups (Met & Cys); group seven contained cyclic R-
groups (His and Pro). Upon incubation with the aaRS, groups that generated a 
measurable signal were investigated further.  The identity of the activated AA 
within each group was determined by incubating individual AAs with the aaRS of 
interest. 
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Table 9  
AA Groups used in the activation analysis  
 
Fig. 38 displays the activation scheme using alanyl-tRNA synthetase 
(AlaRS).  Groups 1 and 4 produced an activation signal (i.e. an increase in the 
TLC AA-AMP spot) and proceeded to the next stage in the analysis. The 
remaining subgroups (2, 3, and 5 – 7 denoted with an x in Fig. 38) showed no 
activation (i.e. no AA-AMP) and were not investigated further.  Next, analysis of 
the individual AAs within subgroups 1 and 4 (step 4) revealed that Gly and Ser 
are preferentially selected.  The TLC images for the positive control, negative 
control, Gly, and Ser assays are displayed in Fig. 39A. Again the AA-AMP is 
represented as the fastest migrating species, followed by the AMP, and 
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unreacted ATP does not migrate appreciably.  The data shown is based on a 
minimum of three independent assays.    
  
Figure 38. Activation scheme for alanyl-synthetase (AlaRS) 
Step 1 is a positive control to ensure enzyme activity, Step 2 is a set of group assays. Step 3 displays the individual AA 
assays. An X denotes no misactivation. Gly and Ser (shown in red) were selected by AlaRS. 
 
Figure 39. TLC results and forward reaction curves for AlaRS 
A) TLC images from AlaRS Pos control (Ala), Neg control (no AA), and individual AA assays for Gly and Ser. Time 
increases from left to right with lanes 1 – 11 representing 0s, 0.08m, 0.17min, 0.33min, 0.67min, 1.00min, 2.00min, 
4.00min, 8.00min, 12.00min, and 20.00min, respectively. B) Forward reaction curve for AlaRS individual AA assays 
showing the Pos control in blue, Gly in grey, Ser in green, and the Neg control in red. 
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6.2 Measurement of Activation Reaction Rates 
Fig. 40 – 51 and Fig. 52 – 61 show the forward reaction curves for the 
class I and class II aaRSs, respectively. Recombinant histidine tagged aaRSs 
were expressed in E. coli and purified using a nickel affinity column according to 
protocols previously reported by Josephson et. al.212 Positive (Pos) and negative 
(Neg) controls are shown for each aaRS along with any misactivated AAs. 
Tables to the right of each graph display AA-AMP concentrations at 20 min, the 
relative initial rates, and the R2 values for each fit. Each data set was fit using 
GraphPad© software, according to its behavior, by one of Eq. 4 – 6. Eq. 4 is a 
simple linear regression where the AA-AMP concentration (C) is equal to the rate 
constant (k) multiplied by time (t). Eq. 5 is an exponential decay function used to 
describe a one-phase association model, where CMax is the maximum AA-AMP 
concentration, k is the rate constant, and t is time. Eq. 6 is a product inhibition 
model used to fit data displaying reversible Michealis –Menton kinetics, where 
CMax is the maximum AA-AMP concentration, t is time, kF is the forward rate 
constant and kR is the reverse rate constant. Relative initial rates are calculated 
from the first derivative of each forward reaction curve. Each graph represents 
the average of at least three replicate assays. 
                             Eq. 4 Linear Model                    
         Eq. 5 One-phase Association Model 
           Eq. 6 Product Inhibition Model 
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CHAPTER VII - RESULTS 
7.1. Analysis of AA Activation Patterns Using Class I aaRSs: 
7.1.1 Analysis of AA Activation Patterns Using ArgRS: 
The forward reaction curves for ArgRS misactivation are shown in Fig. 40. 
ArgRS showed no activity in the presence of its cognate AA, Arg, but showed 
weak misactivation with several noncognate AAs. The presence of tRNAArg is 
known to be required for activation of Arg213, but this is apparently not so for 
misactivation of Ala, Ile. Ser, and Thr. ArgRS produced 0.24 – 0.45 nM adenylate 
concentrations with Ala, Ile, Ser, and Thr. Ala produced a biphasic activation 
profile and had the highest initial rate at 0.026 nM/min.  
  
Figure 40. Forward reaction curves of ArgRS  
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7.1.2 Analysis of AA Activation Patterns Using CysRS:  
CysRS showed no activity toward any of the noncognate substrates 
examined. Fig. 41 shows the forward reaction curve of the positive control for 
CysRS. CysRS produced relatively low concentrations of cognate adenylate 
(1.04 nM) and displayed a slow initial rate of 0.21 nM/min. 
 
Figure 41. Forward reaction curves of CysRS 
7.1.3 Analysis of AA Activation Patterns Using IleRS: 
The forward reaction curves for IleRS are shown in Fig. 42 - 44. IleRS 
activated the second largest number of noncognate substrates of any aaRS 
examined. Val, Met, Thr, Glu, Leu, Cys, and Ala were all misactivated by IleRS. 
Val, Met , and Thr are shown in Fig. 42. IleRS showed remarkably strong activity 
toward Val, exceeding Ile in adenylate production at 20 min. Val, however, 
showed a 3-fold reduction in initial rate versus Ile. Met and Thr also produced 
relatively high levels of adenylate ( > 2 nM) at 20 min with rates approximately14 
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fold less than with Ile. Fig. 43 shows Glu, Leu, Cys, and Ala with the Pos control 
in order to illustrate the weak activation displayed with these substrates. Fig. 44 
shows a zoomed in view of Glu, Leu, Cys, and Ala reaction curves, and clearly 
shows activation above the level of the Neg control.  
  
Figure 42. Forward reaction curves of IleRS with Val, Met, and Thr 
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Figure 43. Forward reaction curves of IleRS with Glu, Leu, Cys, and Ala.  
 
 
Figure 44. Forward reaction curves of IleRS with Glu, Leu, Cys, Ala, and Neg 
control (zoomed view) without the Pos control. 
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7.1.4 Analysis of AA Activation Patterns Using LeuRS: 
Forward reaciton curves for LeuRS are shown in Fig. 45 and 46. LeuRS 
showed activity toward several noncognate AAs, however, for many of these this 
activity was quite weak compared to the cognate AA Leu (Fig. 45). The zoomed 
view shown in Fig. 46 shows LeuRS misactivated Cys, Ile, Phe, Val, Ala, and 
Asp. Cys showed the highest level of misactivation, producing 2.23 nM of Cys-
AMP at 20 min at an initial rate of 0.229 nM/min. This represents a 6.5 fold 
reduction in adenylate concentration and a 37 fold reduction in initial rate versus 
Leu.  
  
Figure 45. Forward reaction curves of LeuRS  
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Figure 46. Forward reaction curves of LeuRS (zoomed view) 
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7.1.5 Analysis of AA Activation Patterns Using MetRS: 
MetRS was the most active aaRS to show no activity toward any of the 
noncognate substrates examined. Fig. 47 shows the forward reaction curve of 
the positive control for MetRS. MetRS produced relatively high concentrations of 
cognate adenylate (14.16 nM) and displayed one of the fastest initial rates at 
8.42 nM/min. 
 
Figure 47. Forward reaction curves of MetRS 
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7.1.6 Analysis of AA Activation Patterns Using TrpRS: 
TrpRS showed no activity toward any of the noncognate substrates 
examined. Fig. 48 shows the forward reaction curve of the positive control for 
TrpRS. 
 
Figure 48. Forward reaction curves of TrpRS 
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7.1.7 Analysis of AA Activation Patterns Using TyrRS: 
The forward reaction curves for TyrRS are shown in Fig 49. TyrRS 
showed noncognate activity toward Cys and Phe. Both Cys and Phe produced 
adenylate levels at 20 min comparable to those seen with Tyr, but with drastically 
different initial rates. Cys displayed an initial rate of 5.72 nM/min, or about half 
that of Tyr. Phe, on the other hand, displayed an initial rate 17 fold lower versus 
Tyr. 
 
Figure 49. Forward reaction curves of TyrRS  
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7.1.8 Analysis of AA Activation Patterns Using ValRS: 
ValRS (Fig. 50 and 51) was the most active aaRS of all those examined, 
both in terms of cognate and noncognate activation. ValRS was also the most 
promiscuous aaRS, showing activation toward a total of 10 AAs (Ile, Leu, Asp, 
Glu, Ala, Ser, Glu, Thr, Met, and Gly). ValRS produced the highest concentration 
of cognate adenylate of any aaRS at 25.79 nM and displayed the highest initial 
rate of cognate activation at 88.64 nM/min. Fig. 50 shows ValRS misactivated 
five non-cognate AAs (Ile, Leu, Asp, Glu, and Ala) to a higher degree, in terms of 
adenylate production, than their respective aaRSs. One non-cognate substrate, 
Ile, produced adenylate concentrations 20% higher than with Val. The initial 
activation rate with Ile, however, was 6 fold less compared to Val. Ser, Glu, Thr, 
and Met ( Fig. 51) showed weaker, but still substantial activation.    
 
Figure 50. Forward reaction curves of ValRS with Ile, Leu, Asp, Cys, and Ala  
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Figure 51. Forward reaction curves of ValRS with Ser, Glu, Thr, Met, and Gly  
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7.2. Analysis of AA Activation Using Class II aaRSs: 
7.2.1 Analysis of AA Activation Using AlaRS: 
Fig. 52 shows the forward reaction curves and accompanying data table 
for AlaRS. AlaRS showed strong activity toward Gly and Ser. Both noncognate 
substrates produced adenylate concentrations comparable to the cognate Ala at 
20 min. Initial rates, however, were 6 – 9 fold lower with Ser and Gly, 
respectively, versus Ala.  
 
 
Figure 52. Forward reaction curves of AlaRS  
 
 
 
 
 
0 5 10 15 20
0
2
4
6
8
10
12
Time (min)
A
A
-A
M
P
 (
n
M
)
Pos
Neg
Gly
Ser
AlaRS
[AA-AMP]
@ 20min
(nM)
10.24
8.99
8.97
0.27
Relative 
Initial Rate
(nM/min)
6.64
0.76
1.03
-
R2
0.96
0.99
0.98
-
 107 
7.2.2 Analysis of AA Activation Using AsnRS: 
Fig. 53 shows the forward reaction curves for AsnRS misactivation. 
AsnRS was shown to misactivate the two acidic AAs, Asp, and Glu. Asp 
produced just under half that of the Pos control with an initial rate 18-fold less 
than the Pos control. AsnRS activated Glu much less efficiently, producing an 
AA-AMP concentration 10-fold less than the Pos control at an 80-fold lower initial 
rate.    
 
Figure 53. Forward reaction curves of AsnRS  
 
 
 
 
 
 
0 5 10 15 20
0
5
10
15
Time (min)
A
A
-A
M
P
 (
n
M
)
Pos
Neg
Asp
Glu
[AA-AMP]
@ 20min
(nM)
7.36
2.81
0.77
0.11
Relative 
Initial Rate
(nM/min)
8.86
0.48
0.15
-
R2
0.86
0.96
0.85
-
AsnRS
 108 
 
7.2.3 Analysis of AA Activation Using AspRS: 
AspRS forward reaction curves are shown in Fig. 54. AspRS displayed no 
cognate activation with Asp (Pos control). AspRS did, however, misactivate Ala, 
Gly, and Ser. Misactivated adenylate concentrations at 20 min were relatively low 
(1.0 – 0.3nM). Ala showed the highest AA-AMP concentration at 1.09nM with an 
initial rate of 2.41 nM/min.  
 
Figure 54. Forward reaction curves of AspRS  
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7.2.4 Analysis of AA Activation Using GlyRS: 
GlyRS showed a surprising level of substrate flexibility, though it was one 
of the least active aaRSs, producing only 0.31 nM Gly-AMP at 20 min. Fig. 55 
shows Ala and Met misactivation produced nearly 50% higher adenylate 
concentrations at 20 min versus Gly, and Ser was misactivated to nearly the 
same degree as Gly. Initial rates for GlyRS were relatively low with Ala producing 
the highest initial rate at 0.55 nM/min.  
 
Figure 55. Forward reaction curves of GlyRS  
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7.2.5 Analysis of AA Activation Using HisRS: 
HisRS was the only class II aaRS to show no activity toward any of the 
noncognate substrates examined. Fig. 56 shows the forward reaction curve of 
the positive control for HisRS. HisRS produced very low concentrations of 
cognate adenylate (0.48 nM) but at a significant initial rate of 6.64 nM/min.  
 
Figure 56. Forward reaction curves of HisRS  
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7.2.6 Analysis of AA Activation Using LysRS: 
LysRS forward reaction curves are shown in Fig. 57. LysRS was one of 
the most active of the class II aaRSs with the highest initial rate of cognate 
activation of any class II aaRS. LysRS produced a biphasic activation profile with 
Lys with an initial rate exceeding 20 nM/min. LysRS showed noncognate activity 
toward Ile, Cys, and Met. All produced relatively high adenylate concentrations at 
20 min, however, at rates 20 – 55 fold lower rates versus Lys.  
 
Figure 57. Forward reaction curves of LysRS  
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7.2.7 Analysis of AA Activation Using PheRS: 
PheRS showed moderate activity toward Tyr. The forward reaction curves 
for PheRS are shown in Fig. 58. Tyr produced only 3 fold less adenylate 
concentration at 20 min, but displayed an initial rate 11 fold lower versus Phe.  
 
Figure 58. Forward reaction curves of PheRS  
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7.2.8 Analysis of AA Activation Using ProRS: 
The forward reaction curves for ProRS are shown in Fig 59. ProRS was 
shown to misactivate Ala. Ala misactivation produced an almost 10 fold reduction 
in both adenylate concentration at 20 min and in initial rate versus the cognate 
substrate Pro.  
 
Figure 59. Forward reaction curves of ProRS  
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7.2.9 Analysis of AA Activation Using SerRS: 
SerRS was shown to misactivate Cys. The forward reaction curves 
showing activation profiles for the Ser (pos) and Cys are shown in Fig. 60. Initial 
activation rates show Cys was activated 50 fold less efficiently than the cognate 
Ser.  
 
Figure 60. Forward reaction curves of SerRS  
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7.2.10 Analysis of AA Activation Using ThrRS: 
ThrRS (Fig. 61 and 62) showed activity toward the highest number of 
noncognate substrates of any class II aaRS. ThrRS misactivated Ala, Gly, Ile, 
Ser, and Cys. Ala was misactivated 3 – 4 fold less efficiently than Thr both in 
terms of adenylate produced at 20 min and initial rate. Gly, Ile, Ser, and Cys 
were activated much less efficiently, producing adenylate concentrations 10 fold 
less than with Thr and at initial rates 20 – 100 fold slower.  
 
Figure 61. Forward reaction curves of ThrRS  
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Figure 62. Forward reaction curves of ThrRS (zoomed view)  
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a great deal of substrate flexibility, misactivating aliphatic, hydroxyl containing, 
acidic, sulfur containing, and aromatic AAs.  
Table 10  
Summary of class I aaRS activation 
 
 
Table 11 shows a summary of class II aaRS activation with aaRSs listed 
horizontally and AAs listed vertically. Again, both are arranged in order of highest 
number of misactivations with an X denoting activation. Nine class II aaRSs 
(AlaRS, AsnRS, AspRS, GlyRS, LysRS, PheRS, ProRS, SerRS, and ThrRS) 
misactivated at least one non-cognate AA. HisRS showed only cognate 
activation. Class II aaRSs showed non-cognate activation to nine AAs (Ala, Ser, 
Gly, Cys, Ile, Met, Asp, Glu, and Tyr), and were also shown to preferentially 
select aliphatic, hydroxyl containing, acidic, sulfur containing, and aromatic AAs.  
ValRS IleRS LeuRS ArgRS TyrRS TrpRS CysRS MetRS GluRS GlnRS
Cys x x x x x
Ala x x x x
Ile x x x x
Thr x x x
Val x x x
Leu x x x
Met x x x
Asp x x
Glu x x
Ser x x
Phe x x
Gly x
Tyr x
Trp x
His
Lys
Pro
Arg
Asn
Gln
Class I aaRSs
 118 
 
Table 11  
Summary of class II aaRS activation 
 
 
Tables 12 and 13 show AAs selected during class I and II aaRS assays 
listed as “Early” with those rejected listed as “Late”. These tables are based on 
the hypothesis that early AAs are more highly selected by extant aaRSs for 
misactivation. For both data sets, the list of early AAs contains a near equal 
number of AAs specific to both classes of aaRSs. Aliphatic AAs (Ala, Ile, Leu, 
and Val), hydroxyl containing (Ser and Thr), sulfur containing (Cys and Met), and 
acidic AAs (Asp and Glu) were selected to a high degree and placed in the Early 
column. The aromatic AA Phe was misactivated by a single class I aaRS, TyrRS, 
ThrRS GlyRS LysRS AlaRS AspRS AsnRS PheRS ProRS SerRS HisRS
Ala x x x x x
Ser x x x x x
Gly x x x x
Cys x x x
Ile x x
Met x x
Asp x
Glu x
Tyr x
Thr x
Leu
Asn x
His x
Phe x
Lys x
Pro x
Arg
Gln
Trp
Val
Class II aaRSs
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and tentatively placed in the Early column. All amide and carboxamide containing 
AAs (Arg, Asn, Gln, and Lys) are placed in the Late column. 
Table 12  
Early vs. Late AAs according to class I aaRS misactivation 
 
Table 13  
Early vs. Late AAs according to class II aaRS misactivation 
Early Late
Cys Tyr
Ala Trp
Ile His
Thr Lys
Val Pro
Leu Arg
Met Asn
Asp Gln
Glu
Ser
Phe
Gly
Class I Chronology
Early Late
Ala Thr
Ser Leu
Gly Val
Cys Phe
Ile His
Met Lys
Asp Pro
Glu Trp
Tyr Arg
Asn
Gln
Class II Chronology
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CHAPTER VIII - DISCUSSION AND CONCLUSION 
8.1 Discussion 
Tables 14 A-C show Early vs. Late AAs based on three of the theories 
discussed earlier. AAs sharing the same box are equal in age according to each 
theory. Table 14A is derived from a consensus of proteinacious AAs found in 
early Earth simulations.137,138,150 Table 14B is derived from the codon-ceding 
scheme proposed in the CET.147 Table 14B shows the results from a consensus 
study examining a set of criteria thought to be associated with AA age.144 This 
study determined an AA chronology based primarily on thermodynamic stability 
and cost of proccessivity. In this study, AAs that are most thermally stable and 
least costly to process were considered to be early AAs. Table 15 shows a 
consensus table derived from Tables 12 and 13 from the current study. AAs 
activated by at least two noncognate aaRSs are considered early. AAs showing 
only a single instance of misactivation along with those showing no misactivation 
are considered late. There is a consensus between all chronologies for a majority 
of AAs. Ala, Ser, Gly, Asp, Glu, Thr, Leu, and Val are considered early by all 
methods. Likewise, Arg, Asn, His, Lys, Tyr, and Trp are considered late by each 
method. Data for Cys, Gln, Ile, Met, Phe, and Pro do not agree between 
methods.  
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Table 14 AA  
Chronologies based on early Earth/meteorite studies, Physiochemical Properties, 
and Biosynthetic Pathways  
   
 
Table 15  
Consensus AA Chronology Based on Class I and II aaRS Activation 
 
 
To further illustrate the compliance of misactivation profiles with the CET 
and AA biosynthetic pathways, Fig. 63 and 64 were generated showing the 
misactivation overlaid onto a schematic of extant biosynthetic pathways (Fig. 63) 
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and the codon-conceding scheme proposed by Wong in the CET (Fig. 64). When 
the AA misactivation data from the current study is overlaid onto the AA 
biosynthetic pathways all of the most highly misactivated AAs (early AAs) 
comprise all of the inner nodes. These are shown in dashed red boxes in Fig. 63. 
AAs showing little or no misactivation are all termination points in the pathways, 
shown in solid blue boxes in Fig. 63. In the biosynthetic pathways shown here all 
intermediate precursor AAs are from the group of highly misactivated AAs (Early 
AAs). AAs showing little or no misactivation (Late AAs) are not precursors of 
other AAs. This illustrates the selection preference of extant aaRSs for AAs that 
are precursors of other AAs and closer to central metabolism. Assuming that 
precursor AAs and AAs closer to central metabolism are more ancient suggests 
that extant aaRSs may have retained some activity toward their ancestral 
substrates (i.e. early AAs) and may suggest a role for ancestral aaRSs in 
primitive biosynthesis of AAs or their intermediates.  
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Figure 63. AA misactivation vs. AA biosynthetic pathways 
AA biosynthetic pathways with AA misactivation results overlaid onto it. Highly misactivated or Early AAs are shown in 
dashed red boxes. AAs showing little or no misactivation are shown in solid blue boxes. From “Amino acid biogenisis, 
evolution of the genetic code and aminoacyl-tRNA synthetases,” by Klipcan et. al.2004. J. Theor. Biol. 228, 389-396. 
Copyright 2004 by Elsevier. Reprinted with permission of the author.146 
 
Fig. 64 was generated, showing the codon-conceding scheme proposed 
by Wong in the CET with the AA misactivation results overlaid onto it. The figure 
shows the proposed evolution of AA codification as codons are conceded from 
older AAs to newer, AAs. In this case the group of highly misactivated AAs (Early 
AAs) again comprise all of the inner nodes. AAs considered Late according to 
misactivation data are terminal points according to this scheme. The correlation 
between the AA selectivity of aaRSs and the codon concession scheme shown in 
Fig. 64 suggests that aaRS may have played a role in AA codification. If extant 
Early	
Late	
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aaRSs have indeed retained activity toward a set of early AAs, this suggests that 
development of aaRS specificity may be linked to the codon concession process.   
 
Figure 64. AA misactivation vs. CET 
Codon ceding scheme proposed in the CET with AA misactivation results overlaid onto it. Highly misactivated or Early 
AAs are shown in dashed red boxes. AAs showing little or no misactivation are shown in solid blue boxes. From “A co-
evolutiontheory of the genetic code,” by Wong 1975, Proc. Nat. Acad. Sci. 72, 1909-1912. Copyright 1975 by Proc. Nat. 
Acad. Sci. Reprinted with permission of the author.147 
There seems to be little relationship between aaRS class and selection of 
AAs for misactivation. Overall, AAs are not selected to a higher degree by aaRSs 
of their respective classes. Six class I specific AAs (Cys, Ile, Val, Leu, Glu, and 
Met) were misactivated by class I aaRSs. Additionally, five class II specific AAs 
(Ala, Asp, Ser, Thr, and Phe) were activated by class I aaRSs. Only four of ten 
class II specific AAs (Ala, Ser, Gly, and Asp) showed misactivation by the class II 
aaRSs. Class II aaRSs showed noncognate activity toward five class I specific 
Early	
Late	
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AAs (Cys, Ile, Met, Glu, and Tyr). The class II aaRSs proved to be more 
promiscuous as a group than the class I aaRSs. Nine of the ten class II aaRSs 
showed activity toward at least one noncognate substrate compared to only five 
of ten class I aaRSs. However, a subset of class I aaRSs (ArgRS, IleRS, LeuRS, 
and ValRS) showed a high degree of substrate flexibility, and activated a higher 
number of AAs. Both classes showed a propensity for excluding many of the 
same AAs. Arg, Asn, Lys, and Gln, AAs containing amide or carboxamide side 
chains, were completely rejected for misactivation. 
8.2 Conclusion 
The data presented in this study suggests that extant aaRSs have a 
selection preference for AAs thought to be among the most ancient. AA 
misactivation profiles shown in Fig. 40-62 and summarized in Tables 11-12 
correlate with the many of the current theories on the evolution of AA recruitment 
and codification, including the CET (Fig. 64). This points to the prospect that 
aaRSs may have played a role in the process of AA codification during some 
phase of genetic code development. This proposition depends heavily on the 
state of the genetic code during the transition from ribozyme-based translation to 
protein-based translation when the ancestors of aaRSs first took up the role of 
tRNA charging. 
It has been suggested that ancestral aaRSs were initially tasked with 
enhancing charging rates in primitive translation with little specificity toward a 
particular amino acid.167 The diversification of aaRS into AA specific enzymes 
could have followed two possible scenarios: i) aaRSs initially developed AA 
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specificity in the presence the genetic code in its current form or ii) aaRSs initially 
developed in the presence of an incomplete set of AAs and AA specificity 
coevolved with the genetic code. The first scenario implies that a fully-fledged 
genetic code existed in an RNA based translation system prior to the advent of 
peptides that assisted in RNA charging (proto-aaRSs). The second scenario 
implies the existence of a primitive genetic code similar to the operational codes 
proposed by Schimmel and Rodin 167,168,173,174,  capable of producing functional 
peptides. Furthermore, it implies that aaRSs were present during a period of 
code expansion and ambiguity reduction.  
The results of this study suggest the second scenario to be more likely 
and support the supposition that ancestral aaRSs were initially tasked with 
enhancing charging rates in primitive translation with little specificity toward a 
particular amino acid. Many extant aaRSs display noncognate activity toward 
AAs thought to be among the earliest. This activity may be a vestige of ancestral 
aaRS specificity toward this group of AAs. If this is indeed the case, it indicates 
that ancestral aaRSs arose during a period of an early operational code with 
fewer than 20 AAs (i.e. the set identified as early AAs) and were present during 
later stages of genetic code development.   
Further, the selection (or misactivation) profiles of extant aaRSs suggest 
that interactions between ancestral aaRSs and AAs may have played a role in 
AA recruitment and in determining the structure of the genetic code. This 
scenario is evidenced by the synthesis of Gln-tRNAGln observed in archea and 
certain bacteria that lack GlnRS132. In these organisms GluRS forms an 
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intermediate of Gln-tRNAGln by mischarging tRNAGln with Glu to form Glu-
tRNAGln.132,214,215 The Glu moiety is then converted to Gln by an 
amidotransferase.132,215 In this manner GluRS participates in the synthesis of an 
intermediate of Gln. The ability of GluRS to charge both tRNAGlu and tRNAGln with 
Glu also provides a mechanism for codon concession that is linked to aaRS 
specificity.  
In a manner similar to GluRS, ancestral aaRSs may have participated in 
the synthesis of new AAs and conceded codons to them, thereby directing the 
recruitment and coding of AAs. The AA selection profiles from this study show 
that extant aaRSs preferentially misactivate AAs thought to be more ancient, 
suggesting that aaRSs may still hold a vestige of their ancestral activity toward 
an early set of AAs. This apparent prefernce for an ancient set of AAs suggests 
that aaRSs origionally developed specificity for this ancient set of AAs and points 
to the likelihood that aaRSs played a part in AA synthesis and codification during 
a period of expansion and ambiguity reduction of the genetic code.   
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